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ABSTRACT 
Clinical professionals in South Africa are generally unaware of the impact of 
obstructive sleep apnoea (OS A). The cost to the state of untreated apnoea may be 
extremely high. In primary health care encounters OSA often goes undiagnosed. 
The cascade of symptoms linked to OSA is profound, placing patients at risk for 
debilitating problems impacting on self and others. The aim of this study was to 
validate a questionnaire, which could be used at a primary health care level to 
identify patients with OSA thus cutting costs and improving efficient, effective and 
ethical service to patients. The Berlin Questionnaire (BQ) (Netzer et al. 1999) was 
administered to a clinical sample of consenting patients at a private sleep laboratory 
in Durban, South Africa (N = 119)(completed n = 110). Home-based sleep studies 
(n = 116) on a portable cardio-respiratory screening device were also obtained for 
objective comparison. From the results obtained in this South African sample, the 
BQ showed low validity and reliability (Cronbach a = 0.62 - 0.84) to individual 
items of the BQ. The total BQ score and high-risk symptom category analysis 
showed mildly significant correlations with internationally approved protocols. The 
BQ identified 60% of the high-risk group (AHI >5). Furthermore, risk categories 
were useful in predicting AHI ratings in 64% of moderate OSA cases and 25% of 
severe OSA cases. The BQ therefore has useful psychometric properties as an 
adjunct assessment tool to screen for high-risk OSA cases where resources are 
scant. Clinical health psychologists are in an ideal position to recognise the risk 
factors and symptoms of OSA. The clinical assessment and the value of the correct 
diagnosis will alleviate the treatment of psychological symptoms at a superficial 
level in primary health care facilities. 
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CHAPTER 1. INTRODUCTION 
1.1. Overview 
Obstructive Sleep Apnoea-hypopnoea1 (OSAHS) is a sleep disorder characterised by 
repetitive episodes of airflow reduction (hypopnoea) or complete cessation of breathing 
(apnoea) due to narrowing of the airway and leading to acute gas exchange abnormalities 
(hypoxaemia) and sleep fragmentation (Olsen, Moore, Morgenthaler, Gay and Staats, 
2003). Untreated OSA is a potentially disabling condition characterised by excessive 
daytime sleepiness (EDS), disruptive snoring and sleep fragmentation (Netzer, Stoohs and 
Netzer, 1999). 
The need for sleep is an essential physiological requirement. Prolonged interference with 
physiological renewal weakens resources for coping with even normal demands and 
causes vulnerability to stressors. "One thing that is for sure is that we must sleep in order 
to stay sane" (Berger, 1970, in Carson and Butcher, 1992, p. 10). The nature of the 
syndrome of OSA, in terms of the severe sleep fragmentation and oxygen desaturations, 
impacts on daily function. Psychological effects such as neuropsychological deficits, 
depression, anxiety and poor quality of life have been implicated (Aloia, 2005; Kjelsberg, 
Ruud and Stavem, 2005; Kryer, 2005; Macey, Hendersen and Alger, 2002; Sand, Hagen 
and Shrader, 2003; Strine and Chapman, 2005; Veale, Poussin, Benes, Pepin and Levy, 
2002; Vonk, 2001). Dement & Vaughan (1999) refer to snoring and OSA as the 
"midnight stranglers". Many patients describe "choking" in their sleep (personal 
The British spelling (i.e apnoea and hypopnoea) as apposed to the American spelling (apnea) is used in 
this text. The acronym OSA is used throughout the text to denote sleep apnoea hypopnoea syndrome for 
easy reference. 
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communication, Dr. D. Hooper, Berea Sleep Laboratory, Durban, January, 2006). The 
impact of OSA is extensive. 
Clinicians in South Africa need to be educated about the implications of a sleep disorder 
such as OSA when patients are referred to them. Treating the various conditions of this 
syndrome such as depression or excessive daytime sleepiness for example, may be a 
waste of time, resources and money while treating the core condition is a more direct, 
economic solution to the problem. All too often sedatives are prescribed for patients for 
'insomnia' when in fact the condition causing sleep fragmentation is OSA. Sedatives are 
potentially lethal for an already undermined airway (Lavie, Pillar & Malhotra, 2002). 
Patients also frequently use alcohol to improve their sleep; alcohol can also undermine 
the airway and worsen OSA (Ibid). 
The clinical condition must be treated first focusing on the root of the sleep problem, not 
simply whether the patient complains of not sleeping or feeling sleepy during the day 
(Schlebusch, 1990). Global opinion is that clinicians should be alert to the presentation of 
OSA and approach the management of patients who complain of symptoms such as 
fragmented sleep and EDS from a holistic point of view (Chokroverty 1999; Rosekind, 
2005; Shamsuzzaman, Gersh and Somers, 2003; Stevens, 2004). Netzer et al. (1999) 
refines this theory with the opinion that "specialist intervention using specialised 
diagnostic equipment and intensive education of clinicians on taking a sleep history 
improves recognition of OSA in primary heath care" (p.485). Furthermore, management 
of OSA requires a multi-disciplinary team and specialised equipment (Rosekind, 2005; 
Wolk, Shamsuzzaman & Somers, 2003). 
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Specialised equipment to diagnose the disorder is overnight polysomnography (PSG) and 
more recently screening devices such as the Pulsatile Transit Time Hypnogram 
(HypnoPTT™) are rapidly gaining approval (Chokroverty, 1999; Schwartz, 2005; Katz, 
Lutz, Black and Marcus, 2003). The essential difference between these two systems is 
that firstly PSG produces sleep staging from electroencephalographic (EEG) recording 
and includes cardio-respiratory parameters, whilst screening devices are purely cardio-
respiratory in nature; secondly PSG is performed in a controlled setting in a hospital sleep 
laboratory whereas screening devices are take-home units (Stevens, 2004; Stradling & 
Davies, 2004). Whist controversy abounds regarding the advantages and disadvantages 
of the two kinds of recording systems, contemporary practice argues that OS A is a 
breathing disorder, so it follows that breathing parameters are the most necessary to 
diagnose OS A (Stradling & Davies, 2004). Furthermore, the advantages of home studies 
outweigh those of hospital-based studies (Ibid). Current consensus on the diagnosis and 
treatment of OS A holds that a good sleep history and clinical impression obtained by the 
clinician, data from overnight sleep recordings and if possible, collateral information, all 
culminate in a report generated by the physician diagnosing the presence and severity of 
OSA (Chokroverty, 1999; Rosekind, 2005; Stevens, 2004; Wolk et al. 2003; Dr.D. 
Hooper, Berea Sleep Laboratory, Durban, South Africa, November 2006). The cost 
however of professional and technical resources remains problematic. 
Diagnostic methods to identify OSA are certainly an elitist option in South Africa due to 
the lack of facilities and resources to diagnose sleep disorders. Whilst the number of 
sleep centres accredited in America has increased by 300%, no such accreditation exists 
in South Africa (Personal communication, Health Professional Council of South Africa, 
Pretoria, October, 2005). The recognition and investigation of sleep disorders is 
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relatively new in South Africa, with the first sleep laboratory being established in Cape 
Town in approximately 1980 (Raine, 1993). Sleep laboratories in South Africa are 
currently limited to the private sector, are costly and have extensive waiting lists. Patients 
from medium and low-income groups do not have access to health care systems providing 
diagnosis and treatment for sleep apnoea (Personal communication, Prof. A. Bhigjee, 
Department of neurology, Albert Luthuli Hospital, Durban, South Africa, October 2004; 
Dr.D. Hooper, Berea Sleep Laboratory, Durban, South Africa, November 2006). 
Given this situation, a strong possibility exists that OSA goes undiagnosed and untreated 
in many individuals. For example, a clinician seldom questions the patient or partner 
regarding snoring or breath holding episodes during sleep, but use superficial questions 
regarding sleep. A focus is placed on the referring problem. One should consider the 
possibility that patients using psychological services in South Africa who complain of 
excessive daytime sleepiness, intractable hypertension, eating disorders (in particular -
obesity) cognitive decline or depression may have OSA, an option that is seldom explored 
in clinical psychology scenarios in primary health care. Chokroverty (1999) and Stevens 
(2004) cite the bed-partner as the most valuable source of clinical history. Invariably, if 
OSA is identified it is because the bed partner, family or friend reports "choking" during 
sleep as an incidental during consultation. 
A subjective questionnaire including the opinion of significant others therefore would be 
the logical answer to refining the identification of OSA in primary health settings. Netzer 
et al. (1999) hypothesised that a questionnaire could be used as a diagnostic tool to 
identify OSA and to address the current gap in terms of refining contemporary clinical 
evaluation. These researchers designed and validated a questionnaire addressing risk 
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factors for OSA in a primary health care setting, namely the Berlin Questionnaire (BQ) 
(Appendix A). They concluded that the BQ provides an adequate means of identifying 
patients who are likely to have OSA and challenged further research in other primary 
health care settings. 
1.2. Purpose of current study 
This research follows recommendations by Netzer et al. (1999) to validate the BQ in 
other populations. The current study sought to examine the degree to which items in the 
BQ were correlated with objective data from the HypnoPTT™, a portable recording 
device used by subjects in their homes during a full nights sleep under the guidance of a 
sleep physician. The HypnoPTT™ is therefore a diagnostic instrument used to identify 
and confirm suspected cases of OSA. Construct validity was the preferred validity 
technique as it is considered to be particularly robust because it is determined by 
correlating subjective data with reliable objective measurement (Kaplin and Sacuzzo, 
2005; Zarins 2005). 
The sample was drawn from a sleep laboratory in Durban, South Africa that currently 
services patients from Durban and surrounding areas referred by general practitioners and 
specialists. The laboratory is geared for patients with medical aid from the private sector. 
The validation of the BQ as a possible diagnostic tool seeks to promote an informed 
approach to clinical health psychology as a means of recognising risk factors for OSA and 
for early detection and prevention of a cascade of OSA symptoms (Shamsuzzaman et al. 
2003). 
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Within the clinical health psychology model suggested by Schlebusch, (1990), this study 
explores the value of using the BQ as a diagnostic tool for OS A in primary health care 
settings in South Africa. The purpose of this investigation is to apply a practical and cost 
effective means of identifying a condition frequently overlooked and under diagnosed at 
an enormous cost to the patients and state (Boll, Perrry, Rozensky and Johnson, 2004; 
Foster, Freeman and Pillay, 1997; Gorin and Arnold, 1998; Petersen, 2000; Schlebusch, 
1990). 
1.3. Conceptual framework 
The overall conceptual framework of this study is presented in figure 1-1. It places OS A 
as the central focus - a debilitating syndrome with complex psychological, economic and 
health consequences. These issues and their implications are explored in the literature 
review. Specifically this research project examines the construct validity of the BQ 
(Appendix A) with a view to its potential use as a diagnostic tool in clinical settings by 
comparing the BQ questions, reported by patients on body mass index, snoring, breath-
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1.4. Aim 
The aim of this study is to investigate the construct validity of the BQ (Appendix A) 
as a diagnostic measure for sleep apnoea syndrome in the field of clinical health 
psychology, by comparing the BQ to objective data recorded in patients tested at a 
sleep laboratory in Durban, South Africa (Netzer et al. 1999; Schwartz, 2005). The 
objective data included respiratory events, oxygen desaturation levels, snoring and 
the number of autonomic arousals recorded in an overnight home-based study. 
The objective of this investigation was to do a preliminary investigation of the validity of 
the BQ with a view to investigating its possible role as a reliable and cost-effective 
diagnostic/screening assessment technique for OSA as a possible health promotion 
strategy. The reason this was felt to be an imperative for health promotion was because 
the risk factors for OSA, in particular, the impact of impaired alertness on personal, 
relational and occupational settings is profound (Wolk et al. 2003). 
It was envisaged that clinicians could use the BQ as an early detection tool to diagnose 
OSA vulnerability in South Africa, thus alleviating long-term biological, psychological 
and social effects, which may have profound impact on safety, health and productivity for 
individuals, communities and the nation. The need for educating health-care workers 
regarding the impact of OSA is vital for accurate case formulation. Furthermore, policy 
change at a national level in relation to cost-effective diagnostic protocols may be 
indicated. 
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1.5. Research questions 
Question 1 
Is there a statistically significant correlation between the BQ items 1-10 and the clinical 
and physiological measures of OSA, namely the AHI, snoring, ANA's and oxygen 
saturation levels? 
Question 2 
Can the BQ be considered clinically useful in the South African context as a possible 
screening and/or diagnostic instrument by applying the physician's final report as the 
dependent variable in the statistical analysis? 
1.6. Organisation of chapters 
Chapter two explores OSA, examines related health issues and highlights important risk 
factors for OSA. Chapter 3 provides an overview of the psychometric and diagnostic 
properties of the BQ as a self-rating scale and the HypnoPTT™ as the objective 
diagnostic tool. Furthermore, a critique and cost analysis of these instruments is 
considered. The methodology chapter - chapter 4, describes the characteristics of the 
study sample, the design and methods used to collect and analyse the data. Results are 
presented in chapter 5. Chapter 6 contains a discussion of findings, together with 
limitations of the current study and directions for further research. 
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CHAPTER 2. THE PHENOMENON OF OBSTRUCTIVE SLEEP 
APNOEA SYNDROME (OSA) 
2.1. Introduction 
In this chapter, common health information, risk factors and treatment of OSA will be 
discussed initially. Thereafter the impact of EDS as a public health risk will be discussed. 
The problem of EDS as a primary expression of OSA will be examined, in terms of its 
psychosocial and psychological effects. The diagnosis and treatment of OSA and the 
economic implications of untreated OSA will then be explored. Finally the clinical 
health psychology model will be explored as a means of initiating OSA diagnosis with a 
view to early detection of the disorder and prevention of the cascade of effects. The ways 
in which clinical psychologists can improve their evaluation of a patient with OSA are 
also suggested. 
2.2. Common health information and risk factors 
At present no South African literature is available to estimate the prevalence of OSA. 
Comparatively, OSA is considered a common problem in other countries and literature 
abounds..American and European studies historically suggest the prevalence rates of OSA 
are approximately 2% in females and 4% in males (Chokroverty, 1999; Stevens, 2004). 
Contemporary estimates in Europe however, purport a higher frequency of 24% in 
middle-aged men and 9% in middle-aged women (Garni, Pressman, Caples et al. 2004). 
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It would appear that African-Americans have a higher prevalence compared to other 
ethnic groups, although no clear evidence for this has been reported (Stevens, 2004). OSA 
is probably under diagnosed in women because women may present differently to men 
with OSA symptoms, with less well recognised snoring or apnoea and more complaints of 
fatigue and hypersomnolence (Loube, 2002; Porkka-Heiskanen, Dzaaja and Arber, 2005). 
The risk for developing OSA increases with age and is strongly correlated with obesity 
and the male gender (Chokrovery, 1999; 2004; Wolk et al. 2003). Common risk factors 
for OSA are headache, excessive daytime sleepiness (EDS), cardiovascular disease, 
metabolic and sympathetic nervous system dysfunction, with hypertension topping the list 
(Chokroverty, 1999; Sand et al. 2003; Wolk et al. 2003; Stevens, 2004; Shamsuzzaman, 
et al. 2003; Verona, Winn, Babineau, Eng, Feldman and Ware, 2005). The ongoing 
research of Wolk et al. (2003) and Shimura, Tatsumi, Nakammura, Kasahara et al. (2005) 
is recognising the coexistence of OSA and obesity. All considered this data implicates 
OSA as a costly and major public health risk of dynamic and multi-level proportions 
(Aloia, 2005; Rosenthal, 2005; Rosekind, 2005; Shamsuzzaman et al. 2003; Shimura et 
al. 2005; Somers, 2004; Svatikova, Wolk, Garni, Pohanka and Somers, 2005; Wolk et al. 
2003; WHO, 1986). The enormity of these side effects, assumes to be a heavy burden on 
health care if left undiagnosed and untreated (Gibson, 2005). For example, untreated 
OSA is associated with the prevalence of chronic hypertension in excess of 40% whereas 
30% of all persons with idiopathic hypertension have OSA (Chokroverty, 1999). 
Snoring is a common concomitant of OSA. American studies report primary snoring 
prevalence in 5-85% of male subjects (mean 32%) and 2-57% (mean 21%) in women - as 
reported by the bed partner (Stevens, 2004). Snoring, also known as "upper airway 
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resistance" on its own can cause oxygen depletion and EDS due to multiple arousals 
during sleep (ibid, p. 78). Stradling and Davies (2004) argue that these findings require 
replication. A recent development has been the recognition that elevated leptin plasma 
levels (a neurohormone which regulates body fat mass and exerts important effects on the 
cardiovascular system) beyond the levels seen in obese patients, are being identified in 
OSA patients (Wolk et al. 2003). These authors also cite other complications such as 
insulin resistance, systemic inflammation, endothelial and renal dysfunction in OSA 
sufferers. 
2.3. The impact of OSA on Public health 
These risk factors make OSA a global major public health hazard (Stevens, 2004; 
Shamsuzzaman et al. 2003; Verona et al. 2005; WHO, 1986; Wolk et al. 2003). 
Moreover, these physiological factors impact directly on the patient causing social and 
psychological dysfunction manifesting symptoms such as interpersonal relationship 
problems, anxiety, cognitive deficits, sexual dysfunction and depression (Aloia, Arnedt, 
Smith et al. 2005; Kjelsberg, Ruud and Stavem, 2005). Prout, Demos, and Morrow 
(2001) found that firstly, the onset of depression can often be traced to the beginning of 
sleep difficulties, and secondly the amount of sleep loss usually correlates with the 
severity of depression. 
Subjects in the severe OSA range are particularly affected. The severe range refers to 
those subjects who hold their breath over thirty times per hour (Stevens, 2004). Feelings 
of depersonalisation, fatigue, tiredness, lack of energy and irritability have also been 
frequently reported in OSA sufferers (ibid). The fact that OSA and obesity frequently co-
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occur and include a cluster of abnormalities broadly considered to be reflective of 
metabolic syndrome is a subject for rigorous contemporary discussion and research 
(Shamsuzzaman et al. 2003). 
2.3.1. Excessive Daytime Sleepiness (EDS) 
There was a time when medicine and psychology examined only constructs relating to 
patients who are awake. No diagnostic or treatment consideration was given to sleep or 
daytime sleepiness. The exact mechanisms of EDS are unclear, yet clearly research 
demonstrates that symptoms of daytime hypersomnolence develop gradually during the 
course of OSA (Guilleminault, Tilkian and Dement, 1976). Generally research reiterates 
that one of the most profound consequences of OSA is EDS resulting in impaired 
performance in perception, reasoning, judgement, decision-making, cognitive slowing, 
memory deficits and increased reaction time (Chokroverty, 1999; Stevens, 2004). It 
seems that EDS has evolved from a "virtually unknown medical condition to one of 
active scientific enquiry" (Rosenthal, 2005, p.485). The Epworth Sleepiness Scale (Johns, 
1991, Appendix C) is a renowned questionnaire used to estimate daytime sleepiness 
(Stevens, 2004). Miletin and Hanley (2003) however, challenge the claim of high 
validation in the ESS. 
There is endless controversy and debate over exactly what EDS is. Dinges (1995, p.4) 
defines EDS as "a neurobiological drive to sleep". Rosenthal (2005) expanded the OSA 
argument over thirty years ago by also suggesting that " the fluctuating nature of changes 
during sleep" such as the sudden dips in oxygen levels caused an "unstable state" in 
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metabolic and central nervous system mechanism, contribute to EDS (ibid, p.480). EDS 
is continually reported in the literature as a major consequence of OSA, yet Stradling, 
Barbour, Glennon and Langfornd (2002) question this claim based on their studies of 
sleep fragmentation and autonomic arousal saying: "these measures were not predictive 
of daytime sleepiness " (p.385). 
The debate regarding EDS is historical with many factors being discussed, including a 
new baby in the house, psychiatric morbidity, chronic sleep deprivation and so forth 
(Thorpy, 2005). To complicate matters further, there are also disputes questioning the 
fact that EDS simply reflects fatigue rather than hypersomnolence, (Brown, 1994). 
Brown broadly defines fatigue as "a subjectively experienced disinclination to continue 
performing the task at hand" or "the results of prolonged activity" (p.298a). Another 
argument is that one can be fatigued yet not sleepy, but Lavie et al. (2002) argue, "people 
with true EDS as apposed to fatigue, often fall asleep unintentionally" (p. 109). 
So to consolidate some sort of understanding of why EDS is relevant to this study, the 
point remains - a normal individual who gets adequate sleep should be able to maintain 
wakefulness during the day (Lavie et al. 2002). When an individual consistently falls 
asleep in passive situations it probably represents a clinical problem (Ibid). If wakefulness 
cannot be maintained, the propensity to fall asleep becomes overwhelming resulting in 
the inability to sustain the task at hand (Brown, 1994; Dinges, 1995). When extrapolated 
to real life situations these tasks could be in occupational settings, whilst driving a car, 
truck, train or bus or in social settings such as in church, watching television, reading in a 
movie, during family gatherings or while making love. Thorpy (2005) gives an overview 
of the clinical significance of EDS. Thorpy suggests EDS is holistic and may include 
medical disorders, central nervous system disorders, psychiatric disorders, medications 
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and primary sleep disorders such as sleep apnoea syndrome, narcolepsy, insomnia, 
insufficient sleep and shift work and Chronic Fatigue Syndrome. 
In summary, the most common contributor to pathological sleepiness is OSA, according 
to Gibson (2005). Clinicians can therefore hardly ignore the implication of EDS in 
patients. EDS may well be a clue to an underlying OSA. A quick diagnostic assessment 
tool such as the BQ may therefore be a valuable instrument for early detection and 
recognition of OSA and the diagnosis and treatment thereof could substantially reduce the 
risk for EDS. This innovation could alleviate many psychosocial and psychological 
effects of OS A. 
2.3.2. The Psychosocial and Psychological effects of OSA 
Historically, snoring, breath holding and EDS has been the marker of jovial discussion at 
family breakfast and dinner tables and in occupational and social settings (Charles 
Dickens's Pickwician Boy is a fine example). Contemporary social dialogue centres on 
themes of fatigue and sleepiness on a regular basis, yet few health care clinicians 
investigate the origins thereof (Personal Communication, Dr. D. Hooper, Durban, South 
Africa, June 2006). A story recounted to the researcher by one of the patients from a 
sleep laboratory, goes as follows: A group of friends went camping. The patient awoke to 
find himself on his stretcher on the banks of the river a great distance away from the 
camp. His friends could not tolerate his snoring and breath-holding attacks, so they 
removed him from the camp. Many family and community narratives regarding clear 
observational data diagnostic of OSA could be recounted, the most common being the 
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offended wife who moves to the spare room. Business men and women have had many an 
embarrassing moment when asked to share a room with a colleague or travel for long 
distances. Generally families and individuals never consider a breathing problem, never 
mind one that occurs during sleep as a potential problem area that requires diagnosis and 
treatment. The genetic component also plays a large role. OSA is known to affect 
generations of men [sic]. Families often tolerate the symptoms of OSA as a familiar 
marker of golden moments in the family. 
At a community level, Aloia (2005) maintains that neuropsychological consequences of 
OSA by way of decreased mental acuity can have significant negative consequences for 
daily function, occupational performance, productivity, motor vehicle safety and 
educational pursuits. Gibson (2005) reports OSA to be associated with poor performance 
in the workplace, a high rate of automobile accidents, with a particularly high rate in 
truck drivers. 
Whilst few studies have evaluated quality of life issues in OSA one can assume that the 
psychological effects as mentioned would have a significant effect on quality of life of 
these patients and their partners. One study however, has contributed to a valuable 
understanding of the concerns patients with OSA have. In a discourse analysis Veale et 
al. (2002) identified abnormal fatigue, snoring, depression, excessive use of alcohol and 
antidepressants, loss of memory, relationship and sexual problems and fear of dying in 
OSA sufferers. Interestingly they cite the non-directed conversation with patients as the 
means by which patients revealed these concerns. They suggest these concerns may not 
have surfaced in a standard medical paradigm. Certain conditions are considered 
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embarrassing for patients. Snoring and obesity certainly fall into the social discourse, 
which alienates and saddens patients (Veale et al. 2002). 
Obesity, which is by definition a Body Mass Index (BMI) over thirty, is a global 
challenge approaching epidemic proportions in the United States of America (97 million 
adults, with a 65% risk for hypertension in women and 78% in men) (Wolk, et al. 2003). 
South Africa closely follows these proportions with 29.2% of men and 56.6% of women 
falling into the obese range. There is no doubt that Obesity has a profound psychological 
impact on the lives of OS A sufferers (Puoane, Steyn, Bradshaw, et al. 2002). 
Obesity is a complex public health problem, which Wolk et al. (2003) describe as 
interacting with race, gender, demographics, genetic, neurohormonal and socio-economic 
factors. These researchers hypothesise that OSA may be an important mechanism 
underlying the association between obesity and hypertension. There is an association 
between increased body weight and the risk of OSA - 10% weight gain is associated with 
a 6-fold increase in the odds of developing OSA. Wolk et al. (2003) however, point out 
that significant weight loss led to significant decrease in apnoea frequency. Furthermore, 
these researchers continue this debate by stating: "whereas obesity increases the risk for 
OSA, sleep apnoea may predispose weight gain and obesity" (p. 1068). Obesity is as yet 
not considered an eating disorder according to DSM-IV criteria however ICD-10 coding 
includes obesity in this category, which seems fitting in the face of cascading risk factors 
and causal relationships such as high blood pressure and heart disease (DSM-IV-TR® -
2000; Sadock & Sadock, 2003). 
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The BQ as an early intervention tool within the clinical health psychology forum, will 
surely initiate early prevention and treatment reducing these debilitating consequences 
and enhance quality of life to some extent. It may seem an insignificant beginning, yet 
Schopper (2000) again points out that the purpose of clinical health psychology is to 
prioritise diseases which impact on public health necessitating health promotion, disease 
prevention and policy reforms. 
2.4. Diagnosis and treatment of OSA 
2.4.1. Diagnosis of OSA - comparing full PSG and screening devices 
It has been argued that OSA is simply a clinical diagnosis characterised by daytime 
somnolence, associated with loud snoring, choking or gasping during sleep, recurrent 
nocturnal awakenings, unrefreshing sleep, daytime fatigue and impaired concentration. 
Sleep physicians agree however that this rationale is too imprecise (Bennett & Kinnear, 
1999). A number of different modalities to assist diagnosis have been used from limited 
channel PSG, videometry, overnight oximetry and nasal pressure monitoring in sleep 
laboratories. The simplest of these is overnight oximetry (recording oxygen saturation 
with a finger or ear probe), which is readily available, easy to apply, relatively 
inexpensive and can be performed at home {ibid; Stevens, 2004). Most intensive care 
units in hospitals have an oximeter. However this type of screening really goes to 
extreme end and it is not possible to differentiate respiratory events, cardiac fluctuations 
or sleep fragmentation. Furthermore, unacceptably high false-positive rates have been 
documented (Bennet & Kinnear, 1999). 
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The polysomnogram (PSG) is a test consisting of many parameters recording data during 
a night's sleep. This data includes electroencephalography (EEG - brain activity), 
electro-occulography (EOG - eye movements) electromyography (EMG - muscle 
activity), electrocardiography (ECG - heart activity), and data from various ancillary 
monitors of respiration effort and airflow, blood oxygen saturation, and audio-visual 
recordings (Stevens, 2004). PSG devices also record the number of snores across the 
night. No standard decibel level is recorded. The PSG can be extended to record virtually 
any parameter required. 
The "use of digital and signal processing and analysis allows the collection of 
virtually any number of biological processes or physical activity that can be 
converted into alternating or direct voltage potential" for the purpose of recording 
physiological variables during sleep (Stevens, 2004, p. 45). 
In summary, PSG equipment or what is commonly known as full polysomnography may 
consist of systems with multiple parameters available or in contrast, may be smaller 
systems excluding brain waves necessary for sleep staging (EEG) and focusing more 
specifically on respiratory parameters. The HypnoPTT™ is a sophisticated contemporary 
unit making use of measuring pulsating blood transit time, and respiratory measurements 
recorded from a belt across the chest and a nasal thermistor, which records oral and nasal 
airflow through a cannula placed under the nose. Pulsitile transit time is measured by the 
time taken for a pulse wave to move from the aortic valve, measured from an electrode 
placed close to the heart to some peripheral site, typically the finger. This measurement 
depends largely on sympathetic nervous system function, adrenergic stimulation and the 
elasticity of arterial walls recorded by electrodes placed in close proximity to the heart 
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and an infra -red ray probe placed on the finger, measuring vascular changes in the nail 
bed in relation to blood pressure surges. 
Thus the term screening devices for OSA, which are used predominantly for diagnosing 
OSA in hospital wards and home settings still, have reasonable accuracy for counting 
events despite sources of error compared to attended centre-based PSG (Netzer, 1999). 
Furthermore, Netzer (1999) criticises full PSG systems by stating that this method also 
has limitations such as first night effect - being in a strange environment, under 
observation and experiencing discomfort due to all the connections. There are therefore 
distinct advantages to home recording systems such as eliminating the first night effect to 
some degree in a familiar environment, and empowering the patient to be interactive in 
the evaluative process, as well as minimal connections (Stevens, 2004). 
The advent of screening devices which exclude EEG and focus on respiratory channels, 
has made a valuable contribution to the evaluation of OSA in terms of cost effectiveness, 
due to the advantage of take-home studies and quick turn-around times (Schwartz, 2005; 
Stradling, & Davies, 2004). 
The HypnoPTT™ in summary is therefore designed as a take-home, user-friendly unit 
where the patient can be recorded in their own environment (Schwartz, 2005). To 
diagnose OSA and evaluate severity, this screening device is considered an adequate 
diagnostic tool (Stradling & Davies, 2004). This device was therefore considered an 
adequate objective measure of OSA against which to compare the BQ questions (Stevens, 
2004). The common factors linking full PSG and screening systems is the nature of the 
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acquired data and the scoring criteria used to elicit data diagnosing OSA (AASM Task 
Force report, 1999; Rechtchaffen & Kales, 1968). 
A diagnosis of OSA is made when devices recording respiratory measures show complete 
occlusion of the airway, known as apnoea, or partial occlusion which is defined as a > 
50% reduction in airway space, known as hypopnoea. The duration of events must last 
for more than ten seconds, and occur more than five times per hour to be called an apnoea 
or hypopnoea (Rechschaffen & Kales, 1968). These 'breath-holding events must be 
accompanied by an oxygen desaturation of more than 4% for the diagnosis to apply. 
OSA severity is categorised according to the Apnoea plus hypopnoea index (AHI), which 
is the number of times per hour the subject holds his/her breath (Stevens, 2004). 
Classification of the severity of OSA varies slightly but is generally accepted as falling 
within the normal range when breath-holding episodes occur between 0-5 times per hour, 
mild between 5-15 times per hour, moderate between 15-30 times per hour and severe 
when the subjects holds their breath for greater that 30 times per hour (Stevens, 2004). 
These AHI ranges are tabulated below: 
Table 2-1. Classification of the Apnoea plus Hypopnoea Index (AHI) in OSA severity 
according to Stevens (2004). 
Normal Range Mild Range Moderate range Severe Range 
0-5 times per hour 5-15 times per hour 15-30 times per hour > 30 times per hour 
Severe OSA is also diagnosed in relation to the severity of snoring and the degree of sleep 
fragmentation across a night of sleep. Micro-arousals and arousals are important 
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markers of sleep fragmentation, which lead to daytime sleepiness and reduced alertness 
(Harrison & Home, 1996; Stevens, 2004). Research has also shown that this reduction in 
attention, reaction and performance causes microsleeps which are brief episodes of 
intrusive sleep (2-30 seconds), impacting directly on occupational and road traffic 
situations (Harrison & Home, 1996; Priest, Brichard, Aubert, et al. 2001). 
Obviously, full PSG still stands as the ideal holistic measurement tool for OSA, and in 
research settings or complicated symptomatology, it is essential for fine detail. 
Furthermore, the clinical evaluation and final compilation of results is the responsibility 
of the sleep clinician. However, from a practical, cost effective, public health care 
perspective, the literature reviewed highlights the fact that the BQ could play a vitally 
important role in early diagnosis, treatment and prevention of OSA. The fact that the BQ 
is non-intrusive, cost effective and takes about twenty minutes to complete, makes it a 
viable option for OSA measurement. 
2.4.2. Treatment of OS A 
The treatment for OSA is multi-faceted. Conservative treatment for OSA management is 
weight loss and dietary management, sleeping position (patients are advised to sleep on 
their sides) and abstinence from alcohol and sedatives (Chokroverty, 1999). Whilst these 
conservative approaches to therapy work well with a group of patients who have mild to 
moderate OSA, the global treatment of choice for moderate to severe OSA is Continuous 
Positive Airway Pressure (CPAP) (Chokroverty, 1999; Shamsuzzaman et al. 2003; 
Somers, 2004; Stevens, 2004; Wolk et al. 2003). 
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CPAP effectively "gets the patient breathing again" by splinting the airway, and 
reversing the detrimental effects of oxygen deprivation. The basic mechanism of a CPAP 
machine is to open the airway by delivering room air at a calculated pressure set by 
laboratory staff, in relation to apnoea severity, or by automatic titration over a number of 
nights. Compliance with CPAP users varies substantially. Not all subjects (who are able 
to afford CPAP machines) continue to use them (Svatikova et al. 2005; Veale et al., 
2002). Aloia (2005) alludes to subtle neuropsychological consequences of OSA and an 
amelioration of cognitive deficits after treatment with CPAP. Compliant subjects 
however report remarkable improvements in their quality of life, and preliminary 
evidence suggests that CPAP may reverse many of the detrimental biological effects 
associated with OSA (Veale, et al. 2002; Richards, 2004). 
The use of a CPAP machine, enhances patients lives and can improve symptoms quite 
dramatically, however it is also daunting for a patient initially and may cause anxiety and 
depression in some patients (Veale et al. 2002). Frankly, many patients find the use of the 
machine humiliating and dehumanising. Side effects such as allergies, sores on the 
bridge of the nose and mask leaks are a constant challenge to compliance with this 
treatment device (Chokroverty, 1999; Stevens, 2004; Personal communication, Dr. D. 
Hooper, Sleep Laboratory, Durban, South Africa, June, 2006; Veale et al. 2002). 
The Ear Nose and Throat (ENT) fraternity are constantly in search of a surgical 
procedure, which will improve the treatment of OSA and do away with the CPAP 
machine and are currently one of the most active groups investigating OSA. To date the 
only valuable surgical treatment is the removal of obstructions in the airway (for example 
large adenoids and tonsils - in children this is very successful) and facio-maxillary 
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surgery to advance the mandible in certain cases (Personal communication, Dr. D. 
Hooper, Sleep Laboratory, Durban, South Africa, June, 2006). 
2.5. Economic implications of OSA 
Rosekind (2005, p.s21) states that despite overwhelming evidence, there is "gross 
underestimation and very little acknowledgement of the risks and costs related to sleep 
loss, reduced alertness and performance for OSA sufferers". As mentioned, sleep 
laboratories have been established globally since the early seventies, particularly in the 
United States of America and Great Britain. Europe followed soon after and research in 
sleep medicine is expanding and gaining more credibility. Sleep research societies have 
been formed producing regular research publications and international conferences to 
disseminate information related to medical and allied professionals. 
Yet despite this growth in empirical studies the investigation and treatment of sleep 
disorders remains a specialised and elitist prerogative. 
The cost of overnight, full PSG in private practice is approximately R 2000 per patient, 
with the bed fee alone costing approximately R 1 100 (R 3 100 in total). CPAP machines 
cost approximately R 4 000 - R 17 00 to purchase. Basic systems are cheaper than more 
complicated systems, which record hours of usage for compliance follow up and at a 
higher level, deliver a dual air system, which literally breathes for the patient. These 
systems are known as Bi-Level or BiPAP machines (costing well over R 30 000) and are 
used for more severe comorbid OSA disorders such as motor neurone disease cerebro-
vascular accidents or central sleep apnoea. These machines are also imported as no 
manufacturer exists in South Africa. 
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For diagnosis and treatment of OSA therefore, an individual has to outlay an amount 
ranging from of R 7 100 - R 20 100. Thus, only patients on medical aid, or able to afford 
these prices can be tested and treated for. Many medical aid societies do not recognise 
the need for these devices, and remain ignorant to empirical data citing only obesity as the 
cause for OSA and therefore exclude patients with OSA from the benefits they offer their 
members OSA (Personal communication, Dr. D. Hooper, director - Berea sleep 
laboratory Durban, South Africa, June 2006; Dr. E. Ebrahim, director, London Sleep 
Centre, June 2006). 
In undiagnosed OSA a private patient suffering with cardiac disease, diabetes and or 
intractable hypertension may spend exorbitant amounts annually to cope with 
polypharmacy requirements. An example would be that of a patient with OSA and a 
persistent high blood pressure which, is uncontrolled by standard hypertensives 
medication (Somers, 2004). Frequently in such cases, the patient is put on to two or three 
different drugs in an attempt to control the blood pressure problem at a great expense. 
The state carries the cost for lower income patients, which can become a heavy burden on 
health care systems. National expenditure increases when conditions such as OSA are not 
diagnosed and treated. No South African statistics are available; however in the United 
States of America the estimated annual costs of untreated OSA is as much as $3.4. Billion 
per annum (Gibson, 2005). The annual cost of motor vehicle accidents, occupational 
accidents and absenteeism escalates incrementally with OSA severity (Rosenthal, 2005; 
Dinges, 1995). 
With heightened awareness of OSA for clinicians, it seems pertinent to explore practical 
means of addressing this condition through first line primary health care clinicians. 
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Clinical health psychology forms an integral part of modern health care delivery services. 
Whilst the model assumes that patients are empowered to be more responsible for their 
own health, it seems important that the practitioner's understanding of the OS A syndrome 
and its correlation with mental health and psychosocial stressors, places the patient in a 
better position to become fully functional (Schlebusch, 1990; Schopper, 2000). 
2.6. OSA and clinical health psychology 
2.6.1. Introduction 
As discussed, empirical data suggests that psychological effects such as depression, 
cognitive function (vigilance, memory and executive function) and anxiety, are common 
symptoms noted in patients diagnosed with obstructive sleep apnoea, particularly those 
subjects in the severe range (Aloia, 2005; Kryger, 2005; Macey et al. 2002; Vonk, 2001). 
These deficits have been noted particularly in relation to incidents of snoring, oxygen 
depletion, arousals and the number of respiratory events per hour (Aloia, 2005; Vonk, 
2001). Furthermore, studies with volunteers showed that after seventy two hours of 
fragmented sleep, increasing psychological problems such as disorientation and 
depersonalisation occurred (Carson & Butcher, 1992; Dement, 1999). Psychologists 
consulting patients in primary health care could therefore be far more focused on 
behavioural symptoms at the expense of a far greater health risk. Behavioural symptoms 
impacting on public health are however only the surface features of OSA. An approach, 
which does not provide comprehensive health care, is possibly selling the system short 
(Petersen, 2000). 
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Schlebusch, (1990) suggests that biopsychosocial health care (largely contained within 
the clinical health and behavioural medicine models) is not simply treating psychological 
symptoms such as eating disorders, depression or anxiety at a surface level in the face of 
extensive impaired biological and neurological dysfunction, but rather requires an 
understanding the development of disease and mental disorders. Similarly, Olsen et al. 
(2003) concur with many authors that treating symptoms such as EDS, impaired 
vigilance, mood disorders, obesity and cognitive dysfunction, which are all features of 
OSA is pointless. A condition such as OSA is much broader than simply recognizing the 
condition and referring on for management, it impacts directly on patients and family 
quality of life. It requires professionals trained in recognition of the disorder. 
2.6.2. The Clinical Health Psychology model and primary health care 
The clinical health psychology model is patient centred and focuses on health promotion 
rather than disease prevention within the social structure of a medical setting in primary 
health care (Schlebusch, 1990). Primary health care is provided by a health professional, 
which is at the patient's first point of entry into the health system (Keleher, 2001). 
Primary health care includes the "interconnecting principles of equity, access, 
empowerment, community, self-determination and intersectoral collaboration and the use 
of appropriate technology" providing continuity of care, health promotion and education 
(ibid, p. 57). The clinician has to be alert to a mirroring of symptoms. In other words, a 
[sleep disorder] such as [sleep apnoea] may mask psychiatric symptoms on the one hand 
yet on the other hand reflective psychiatric symptoms could also mask an underlying 
[sleep disorder] (Boll et al. 2004; Schlebusch, 1990). Amongst the psychiatric disorders 
commonly linked to OSA encountered in clinical practice are major depressive disorder, 
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dysthymia, seasonal affective disorder, generalised anxiety disorder, somatoform 
disorders, dissociative disorders, and substance abuse (ibid, Chokroverty, 1999). Boll et 
al. (2004) encourages clinical psychologists to be alert to a concise explanation of any 
disease process in their patient. 
An understanding of the development, progression and treatment of disease refines 
diagnosis and treatment and improves the quality of life of their patient (Ibid). The 
emphasis is on teamwork with the psychologist in a clinical and mediatory role informing 
and empowering the patient to identify and acknowledge their condition, understand the 
implications and risk factors and investigate best approaches to treatment (ibid). 
Rosekind, (2005) further supports this approach to educating the patient about his/her 
symptoms stating that this mode empowers him/her by causing an awareness of risk 
factors and initiating a change process. Boll et al. (2002) emphasize that the 
psychologist's role is not merely as therapist but includes drawing on the skills and 
knowledge of other professionals and assessments, if necessary making appropriate multi-
disciplinary referrals, refining diagnosis and treatment. 
Although OSA: "is a potentially disabling condition characterized by EDS, disruptive 
snoring, repeated episodes of upper airway obstruction during sleep, and nocturnal 
hypoxemia ... , recognition of OSA by community [clinicians] is however, low" (Boll et 
al. 2002; Netzer et al. 1999, p.490). Stoohs et al. (in Netzer et al. 1999) estimated that 
20% of a primary health care patient population may have sleep-disordered breathing. 
Astonishingly, Netzer et al. (1999) identified a .3% case recognition rate amongst primary 
health care physicians. In one study, only 7% of women and 12% of men who have 
moderate to severe OSA received the diagnosis of OSA from a clinician. 
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Petersen (2004) presents a unique concept, which takes into account the role of 
psychologists playing a consultancy-liaison role in clinical health psychology at a primary 
health care level. The argument for Petersen's research is for a "new psychological 
professional to fill the gap for specialized services in South Africa" (p.33). This concept 
could be expanded to a 'new psychological professional to fill the gap in sleep disorders 
medicine'. 
Boll et al. (2004) are critical of clinicians in terms of OS A diagnosis commenting on the 
fact that the diagnosis of OS A is often overlooked because patients and their clinicians 
are unaware of the symptoms and clinical findings of OS A. A clinical understanding of 
any sleep complaint must always begin with an understanding of the disorders listed in 
the DSM-IV-TR® and ICD10 codes (DSM-IV-TR® - 2000; Saddock & Sadock, 2003). 
Sleep apnoea is considered an intrinsic dyssomnia diagnosed on Axis III (ibid). A 
detailed sleep history should be obtained on intake of the patient, preferably in the 
presence of a bed partner or family member. Questions should include sleep habits and 
sleep hygiene (the routines and rituals around sleep), and medication the patient is on, 
alcohol consumption, history of psychiatric and/or neurological disease, medical history, 
family history and any psychosocial problems (Chokroverty, 1999; Stevens, 2004). The 
simple alternative is asking the patient to report their symptoms (Ibid). 
Whilst it is acknowledged that clinical psychologists could improve their diagnostic skills 
simply by taking a more concise sleep history, further investigation is also warranted. 
Objective investigations such as the PSG provide this extension, however questionnaires 
are often the baseline investigation that can be used in a primary health care setting 
(Netzer et al. 1999). The questionnaire used however, must be a credible document. 
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Importantly, questionnaires cannot simply fill the gap; the empirical soundness of an 
instrument must be investigated for clinical application to be recognised and to be 
appropriate (Boll et al. 2004). 
Sleep questionnaires such as the Epworth Sleepiness Scale (ESS) have been used 
extensively as a quick evaluate screening tool for daytime sleepiness (Johns, 1991) 
(Appendix C). The BQ has of late been used to exclude OS A in the USA and Europe 
(Chokroverty, 1999). Such questionnaires should not simply be accepted as clinically 
useful, when extrapolated to a South African population until validated in such a 
population. Whilst the ESS has been used extensively and proves to serve a baseline for 
daytime sleepiness, a more stringent screening of OS A may be provided by the BQ. 
Therefore, it seems appropriate within the clinical health psychology scenario, to 
investigate the psychometric properties of the BQ in a South African population to refine 
clinical intake, and enhance diagnostic and treatment protocols. A basic tool such as the 
BQ could also be an intervention tool for disease prevention and health promotion 
shifting future outcomes in terms of risk factors and consequences of OS A. 
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CHAPTER 3. PSYCHOMETRIC AND DIAGNOSTIC PROPERTIES OF THE BQ 
AND HYPNOPTT™ 
3.1. Introduction 
This chapter starts with a brief general evaluation of psychological assessments and 
explores the meaning of psychometric properties. Thereafter validity is examined in 
more detail, with particular reference to construct validity. The BQ is investigated as a 
potential diagnostic tool by way of giving a history of the BQ development and statistical 
analysis and a cost analysis thereof. 
3.1.1. Psychometric assessment procedures 
Psychological assessments are standardised procedures, which test selected variables 
related to a diagnostic question, whether it is for intelligence, personality or clinical 
conditions such as depression. For any test to be standardised a population has to be 
tested in surroundings which are consistent, controlled and conducive to the subject 
producing the best possible performance (Babbie, 2004; Kaplin & Saccuzzo, 2005). In 
the case of the biopsychosocial paradigm of this research, the assessment tool pertains to 
diagnosing sleep apnoea syndrome with a view to enhancing formulation for holistic 
management of the patient. Zarins (2005) states how important it is to be aware that a 
questionnaire that has been validated for one clinical condition is not valid when applied 
to another condition - it has meaning for a specific entity. The BQ is the instrument of 
choice selected as a potential gold standard measure already used tentatively to identify 
patients with OS A in the severe range when the AHI is over 5 per hour. Sharma, 
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Vasudev, Sinha, Banga, Pandey and Handa (2006) have recently published work done in 
India at a primary health care level. An accurate diagnosis would be advantageous to 
understand the underlying process manifesting psychological distress. In order to do this a 
number of psychometric properties of the questionnaire need to be investigated. 
The term psychometric properties, refers to the validity and reliability of an instrument. 
Validity is effectively an "agreement between a measure and the quality it is supposed to 
measure" or "does the test measure what it is supposed to measure" (Kaplin & Saccuzzo, 
2005, p. 134). The purpose therefore is to achieve precision and accuracy in our 
investigation (Babbie, 2004). Gregory (2004) however also points out that "a test is valid 
to the extent that inferences made from it are appropriate, meaningful and useful" (p. 97). 
Validity is the measure that represents evidence supporting the intended interpretation, or 
is reflective of a concept of a measure, and is central to the use of psychological testing. 
Validity cannot be defined if the test is not reliable. Reliability suggests that the test is 
relatively free of error and associations between items are consistently accurate. "In 
clinical settings, reliability is extremely important when tests are used to make an 
important decision about a patient's future" (Babbie, 2004, p. 124). 
3.2. Validity 
In summary, validity essentially refers to an instrument that is standardised in a large 
cohort and tests specifically what it is designed to test. 






Criterion-related evidence serves to confirm how well a test corresponds with a particular 
criterion. In this case for example the criterion might be the AHI or "breath-holding" 
episodes, or snoring or daytime sleepiness, which are the markers of sleep apnoea 
syndrome. This type of evidence also frequently has a predictive quality to it, a forecast 
of sorts -predictive validity evidence. Criterion evidence is invariably reported by 
professionals such as the attending physician, specialists, psychologists or technicians 
involved in test procedures, diagnosis and treatment of a sleep disorder. The reports of a 
spouse, partner or family members are also crucial. 
Concurrent-related evidence is generated by simultaneous relationship between the test 
and criterion. Content validity refers to a correspondence between item content and the 
domain the items represent, which in health care research is most often diagnostic criteria 
and symptom presentation (Kaplin & Saccuzzo, 2005, p. 156). Face-validity is also 
commonly explored, although it does not have the same empirical base as the others as it 
is based on "appearance", in other words it requires judgment as to whether the 
questionnaire has meaning regarding the condition being investigated. The user-
friendliness of a questionnaire is explored with the subjects and specific areas of 
difficulty may or may not be identified. 
The key psychometric measurement of this study is that of construct validity, which 
defines a "construct" invariably in the form of an objective measure or evidence about 
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what the test is evaluating and is used commonly in health care scenarios. The objective 
measure of choice in this study is the HypnoPTT™ sleep analysis unit, which is a system 
gaining more recognition globally for recording parameters diagnostic of symptoms of 
OSA because of it's sensitivity to cardio-respiratory signals and autonomic arousals 
(Bennett & Kinnear, 1999). A convincing relationship should be established between the 
subjective and objective measures if the instrument under question is valid. Convergent 
evidence will be obtained if the measures of the selected instrument correlate well with 
the BQ. 
Although categories for grouping are convenient to a large degree, the use of categories 
does not imply distinctive forms of validity and contemporary research suggests 
controversy regarding categorization (Kaplan & Saccuzzo, 2005). "Sometimes 
psychologists have been overly rigorous about making distinction amongst categories that 
overlap" (Messick, 1998, in Kaplan & Saccuzzo, 2005, p. 134). To a large extent, 
construct validity does not use single criteria as evidence but is also based on hypotheses 
and clinical judgement of the researchers ... "we would expect that..." which provides 
evidence for inferences to be made. This research therefore applies a holistic approach to 
reporting validity and focuses particularly on contemporary research criteria and risk 
factors for OSA (Chokroverty, 1999; Netzer et al., 1999; Rosekind, 2005; Stevens, 2004; 
Stradling & Davies, 2004; Wolk, et al. 2003) in the context of subjective (BQ) versus 
objective (HypnoPTT™-physiological data). 
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3.3. The Berlin questionnaire as a potential diagnostic tool for identifying OS A 
3.3.1. Background 
The conference on Sleep in Primary Health Care held in Berlin, Germany in April 1996, 
established the need for an efficient questionnaire to screen for sleep apnoea (Netzer et 
al.1999). A group of physicians, from various countries and experienced in sleep 
disordered medicine reviewed literature to elicit factors or behaviour that consistently 
predicted the presence of sleep disordered breathing. The BQ focuses on risk factors for 
sleep apnoea such as snoring behaviour, waketime sleepiness, obesity, (BMI) and 
hypertension. The researchers evaluated the usefulness of using the BQ in primary care 
settings. They also devised a plan for high risk-grouping to simplify recognition of OS A 
(Table 3-1). To be considered high risk for OSA, a patient had to qualify for at least two 
symptom categories. The remaining patients were placed in a lower risk group (Netzer et 
al. 1999). 
Table 3-1. Table showing the BQ High-risk grouping for OSA according to 
Netzer et al. (1999). 
Category 1 
Snoring - Persistent symptoms 
>3-4 x per week 




>3-4 x per week 
wake time sleepiness 
driving or both 
Category 3 
History of high blood 
pressure 
Or 
BMI > 30Kg/m2 
3.3.2. The BQ as a diagnostic tool 
The BQ was the first instrument validated to screen for sleep apnoea in a primary health 
care population (Netzer, 1999; Stevens, 2004). The current study, according to the 
researcher's knowledge, is the first to validate the BQ in a South African setting. A 
number of other studies are currently underway in Germany and the USA (Personal 
communication, Professor V.K. Somers, Director, Sleep Research Laboratory, Mayo 
Clinic, Rochester, USA, October 2004, July 2006; Suharma, Vusudev, Sinba, Banga, 
Pandey and Handa (2006). More than 37.5% of the outpatient's sample visiting an urban 
primary care physician reported risk factors (body mass index >30kg/m2 and 
hypertension) for and chronic behaviours (snoring & EDS) that suggest the presence of 
sleep disturbances and sleep apnoea (Netzer et al. 1999). In a specialized respiratory sleep 
unit the ability of the questionnaire to predict an elevated AHI was similar to that of sleep 
studies using a portable sleep-monitoring unit categorically similar to the HypnoPTT™. 
The EdenTec™ produced by the same company, has four channels for recording 
respiratory variables and does not include the sophistication of pulse transit time 
measurement (ibid). 
3.3.3. Cost analysis of the BQ 
The BQ is convenient, less intrusive to the patient and less costly as clinicians can screen 
for OSA during patient intake. The costs incurred for printing and stationery are probably 
the most important factors. From a psychosocial point of view, according to the literature 
reviewed, the cost to patient, family and community is immeasurable if the patient is not 
tested. 
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3.3.4. Validity and reliability of the BO 
The reliability of individual questions within the symptom categories was examined as a 
measure of internal validity. The Cronbach a value was 0.92 for items in category 1 and 
0.63 for category 2. When questions about sleepiness behind the wheel were excluded, 
the Cronbach a increased to 0.86 (Netzer et al. 1999). The predictive ability of the BQ is 
higher when BMI and blood pressure (symptom category 3) are used in combination with 
snoring or sleepiness, than alone. A sensitivity of 86% for an AHI more than 5 was 
reported in this sample, which is higher than current strategies used in clinical practice 
(ibid). Garni et al. (2004) acknowledge that overnight sleep studies remain the gold 
standard for the diagnosis of OS A, yet they report an 86% predictive rate of cases for 
OS A and also that 97% of the cases predicted for OS A were positive on overnight PSG. 
3.3.5. Critique of the psychometric properties of the BO 
The BQ was used initially to screen for sleep apnoea in a specific primary heath care 
population and reliability and validity were not tested more extensively. Whilst the 
authors comment on the approach to testing being more acceptable to patients, less costly 
and more convenient, criticism could be leveled at the lack of personal interaction clinical 
evaluation of the patient, which may not suite all patients. The face validity of the BQ 
was not investigated. While the questions may be appropriate in an American English 
population, the suitability for cultural diversity is narrowed by the use of language such as 
"up to par" and "how often do you quit breathing". 
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It is important to note that the BQ is not a diagnostic measure, which relies on the 
reporting of symptoms, but rather a syndromic cluster of risk factors within the categories 
in Table 3-1. The authors state unequivocally that whilst the BQ is a sensitive diagnostic 
tool, it does not detract from the fact that clinical judgement is still required to detect 
unusual cases or recognize other causes for daytime sleepiness, other than sleep apnoea 
(ibid). Moreover, the BQ was only considered a diagnostic tool comparable to objective 
assessment in a specialized clinical setting; those patients already clinically suspected of 
having respiratory disturbance. Thorpy (2005) argues that for some clinicians a careful 
interview and the adjunct use of the ESS, which is short and concise, is all that is required 
to assess impairment in alertness, yet even this critique seems inadequate - the BQ 
extends the diagnostic clinical value. In other words not simply in the context of 
excessive sleepiness symptoms, but to risk factors for OS A (Netzer et al., 1999). 
Suharma et al. (2006) state: "the BQ can identify high risk subjects and can thus avoid 
unnecessary PSG studies especially in resource-limited settings". 
3.4. The HypnoPTT™ as a diagnostic tool 
3.4.1. HvpnoPTT™ analysis 
Essentially, the most important parameters of sleep recording for the diagnosis of OS A, 
are the measure of inspiratory effort, the oxygen saturation measures and the estimated 
number of arousals These parameters, it became obvious, could be derived from an 
indirect estimate of beat-to-beat blood pressure or pulse transit time. Whilst a lot of 
criticism has been leveled at the use of screening devices in the past, contemporary sleep 
medicine practice is shifting to more practical ways of diagnosing and treating OS A 
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(Personal communication Dr. D. Hooper, Berea Sleep Laboratory, Durban, South Africa, 
February, 2005). In particular, Stradling, et al. (2004) promotes pulsitile transit time 
measurement as a robust diagnostic measure for OSA. 
Researchers began to study how the HypnoPTT™ could contribute to the management of 
OSA. They concluded that "HypnoPTT™ can provide a non-invasive estimate of 
inspiratory effort and a measure of arousals that together documents disease severity and 
response to treatment and may be very useful in managing obstructive sleep 
apnoea/hypopnoea syndrome" (Pitson & Stradling, 1998, p. 692). 
3.4.2. Cost analysis of the HypnoPTT™ 
The HypnoPTT™ as described, is one of the screening systems available in South Africa 
to clinicians working in sleep medicine at a cost approximately R 200 000. In contrast, 
full PSG system can cost anything up to R 750 000 to set up. Once the HypnoPTT™ has 
been purchased, the usefulness as a home study unit, which is charged at a lower rate to 
laboratory studies (no bed fee charged), makes this unit a more cost-effective option. The 
unit is compact and user-friendly which makes it easy for laboratory staff to explain the 
procedure of recording at home. The unit can also be used from ward to ward in a 
hospital setting to screen in-patients (Personal communication, Dr.D. Hooper, Berea 
Sleep Laboratory, Durban, South Africa, June 2006; Schwartz, 2005). 
The cost of setting up full PSG units has proved problematic for provincial units in SA. 
The only research unit currently functioning in South Africa is at the University of 
39 
Witwatersrand which relies on sponsorship for survival. Albert Luthuli Hospital in 
Durban has a unit available but no posts and staff to run the unit. The ENT unit at Albert 
Luthuli Hospital has initiated the use of portable screening devices, with the assistance of 
the nursing staff (Personal communication, Dr.D. Hooper, Berea Sleep Laboratory, 
Durban, South Africa, November, 2006). 
3.4.3. Validity and Reliability of the HypnoPTT™ 
Pitson & Stradling (1998) investigated HypnoPTT™ and overnight full PSG and divided 
patients into three groups according to the severity of their disorder. Some patients were 
tested in the laboratory and others at home. The reproducibility between the laboratory 
and home studies was reasonable (r = 0.87 for inspiratory BP falls and r = 0.81 for 
arousals). Differences between between the groups were significant (p <0.001 for 
inspiratory falls, /> O.0014 for BP arousals). These authors found the HypnoPTT™ 
instrument to be a reliable diagnostic tool for differentiating the AHI, oxygen saturations, 
arousals and respiratory irregularities. 
3.4.4. Critique of the diagnostic properties of the HypnoPTT™ 
The obvious disadvantage of the HypnoPTT™ systems is the fact that EEG is excluded. 
This means that no brain wave activity to evaluate sleep staging and cycling is recorded. 
EEG waveforms are one of the most important markers of sleep pathology in scientific 
laboratories, and undividedly form the backbone of PSG for documenting and 
differentiating sleep disorders such as insomnia, restless leg syndrome, periodic limb 
movement disorder and nocturnal epilepsy (Chokroverty, 1999; Stevens, 2004). In 
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clinical settings however, when a quick diagnosis and initiation of treatment are 
paramount, HypnoPTT™ systems hold their own and adequately differentiate respiratory 
and cardiac events and arousal (Pitson and Stradling, 1998). The face validity of such a 
system is therefore strong however, Olsen et al. (2003) report that the construct validity of 
the HypnoPTT™ system is reasonable and should be viewed guardedly. 
In a review for clinicians on OSA management and treatment, Olsen et al. (2003) are 
cautious regarding the use of screening instruments for diagnosing OSA. Their 
reservations are supported by retrospective research and the fact that reimbursement for 
CPAP machines is not recognized if the sleep study is not performed in a monitored 
hospital setting and based on at least 120 minutes of recording. All researchers however 
do not support this opinion. The perception that screening devices are invalid is changing 
rapidly in view of the distinct advantage of doing home studies and the similarity of the 
raw data recorded and analysed by digital software (Pitson and Stradling 1998; Personal 
communication, Dr.D. Hooper, Berea Sleep Laboratory, Durban, South Africa, June 
2006; Stevens, 2004; Swartz, 2005). There is no doubt that in poorly resourced primary 
health care settings full PSG is impractical. One or two screening devices in each facility 
would be efficient and effective for objective diagnosis for OSA in the severe range after 
initial clinical and subjective evaluation is made. 
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CHAPTER 4. METHODOLOGY 
4.1. Design 
This study uses a prospective self-report survey to investigate the construct validity of the 
BQ in a clinical population. All patients were from an adult population sent to a sleep 
laboratory in Durban, South Africa for suspected nocturnal respiratory disorders (OSA is 
the primary referral question). Therefore no exclusion criteria or controls were used - the 
patients were considered a specialized group clinically screened by their physicians and 
referred for OSA. Test-retest reliability was not measured - the questionnaires were 
administered once on clinical intake. 
4.2. Hypotheses 
4.2.1. Hypothesis 1 
There is statistically significant correlation between the BQ items 1-10 and the 
physiological measures of OSA, namely the physician's report, which includes the AHI, 
snoring, ANA's and oxygen saturation levels in a clinical adult South African population. 
4.2.2. Hypothesis 2 
Using the physician's report, which is a clinical evaluation including the sleep study 
results, as the dependent variable in statistical analysis, the BQ will demonstrate sufficient 
sensitivity to OSA symptoms, to justify its use as a screening and/or diagnostic 
instrument in the South African clinical context. 
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4.3. Patients 
A convenience sample of OSA patients was obtained from the sleep laboratory in Durban, 
South Africa between June and November 2005. The study criteria included all races and 
gender in an adult population (>21 years old). In total, 109 subjects came to the sleep 
laboratory for overnight sleep studies. Ninety seven (97) patients consented to participate 
in the research project. Patients completed the BQ after clinical evaluation, before 
receiving instructions on the use of the HypnoPTT™. The respondents are representative 
of a socio-economic class that is able to afford private medical care. 
4.4. Ethics and consent 
This research was conducted in accordance with ethical guidelines, as described in the 
Psychological Association of South Africa: Ethical Code for Psychologists. The School of 
Psychology, University of KwaZulu-Natal (Pietermaritzburg) ethics committee and the 
sleep laboratory in Durban, South Africa approved the protocol of this dissertation 
(Reference: HSS/06056A). Human rights and professional ethics were adhered to at all 
times. This study is non-invasive and did not pose any harm to the subjects, cause 
alienation or dehumanization to those who volunteered to take part in the study. The right 
to withdraw at any time, not to be labeled and to privacy was guarded. No patient names 
or details were entered onto the questionnaires. Only coding was used. Both the 
researcher and the sleep physician uphold the confidentiality of the study in terms of the 
data recorded. All records are kept to locked cabinets in the physician's office or in the 
researcher's study at home. 
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Verbal consent was obtained from each patient prior to completing the BQ. The 
physician explained the facts regarding the nature of the BQ and the research project to 
patients in detail. He highlighted the fact that he does not rely on the BQ responses in 
any way to make a diagnosis of OS A. The BQ does not influence, nor is it any part of the 
diagnostic procedure. Netzer et al. (1999) considered verbal agreement and completion 
of the BQ as adequate consent. Likewise, in this study the fact that the subjects agreed to 
complete the BQ was considered consent, after detailed explanation of the rights of the 
patient using an ethical guideline consent format (Appendix D2). This included 
permission for the researcher to have access to patient files. This method was used in 
preference to written consent, which can violate the confidentiality of patients. All 
patients were informed regarding the confidentiality of the study. The BQ was completed 
in the presence of the physician. To standardised the procedure, the patients completed 
the questionnaire in the physician's office, which was a private, uninterrupted setting 
(Appendix Dl). 
4.5. Procedure 
The procedure was threefold. Firstly, the attending physician at the sleep laboratory 
obtained a sleep history during clinical intake, which included demographic data, blood 
pressure (reported), a Body Mass Index (BMI) calculation using the height and weight of 
the patient and subjective reports of sleep problems. Secondly, the patient was informed 
regarding the BQ and consent was obtained to complete the questionnaire. A translation 
into isiZulu, the local African language was provided for patients who did not speak 
English. All patients chose to complete the questionnaire in English. The isiZulu 
questionnaire was therefore not used but is available for perusal in Appendix B. It is 
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envisaged that this questionnaire will be available to other researchers for validation in a 
population including more isiZulu speakers. 
Thirdly, the patient was sent home with the portable overnight home-study unit capable of 
recording data throughout the night. The subjects managed the HPPT™ at home, after 
detailed instruction. The system is user friendly, requiring the attachment of a nasal 
canulla, an oximeter probe attached to the index finger, and two electrocardiogram leads 
attached to the left chest area. These leads recorded airflow, oxygen saturation, pulsatile 
volume and heart rate respectively. 
4.5.1. The Berlin Questionnaire (Appendix A) 
Patients completed the questionnaire at the physician's desk, but the physician did not 
contribute to the answers in any way. The patient was able to ask the physician for 
assistance if they did not understand questions after the physician explained in detail the 
purpose of the study and gave instructions on how to complete the questionnaire. The 
physician reported that patients made very few enquiries; and generally found the BQ 
questionnaire user-friendly. The questions asked were generally regarding occasional 
clarification of the meaning of words or expressions such as "up to par" and "quit". 
Some patients felt it was important to take part in the study as they felt it contributed to 
research, which they said may help others in the future. 
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4.5.2. The HypnoPTT™ 
The procedure for obtaining HypnoPTT™ data during sleep was as follows: 
1. The physician instructed the patient on the home recording of the HypnoPTT™ 
performed a dummy run with the patient and sent him/her home for the night with 
the HypnoPTT™ equipment. 
2. The patient attached and removed the equipment, and initiated and terminated the 
HypnoPTT™ machine him or herself, returning the equipment to the sleep 
laboratory the following day. 
4.6. Data analysis 
The results were analysed using the Statistical Package for the Social Sciences (SPSS®' 
for windows, version 11.5 and 13 (SPSS®, Inc., 2006). Missing data was accounted for in 
the analysis as a 'no entries' due to the fact that some patients completing the BQ did not 
qualify for HypnoPTT™ data analysis (incomplete or spoiled studies) and vice versa and 
furthermore, individual variable data was missing selectively across measures of both the 
BQ and the HypnoPTT™. This was due to many factors such as subjects not 
understanding questions or simply not knowing the answer in the BQ and therefore 
leaving out these items, or parameters not recorded on individual physiological measures 
of HypnoPTT™ data. Individual variables therefore differ in the total number 
represented. Missing data are expressed in the percentage of completed questionnaires 
and in the total number of subjects for each variable. 
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4.6.1. Data loading and analysis 
The variables questioned on the BQ asked the subject to record: 
1.) Height and weight (the physician and/or researcher calculated the BMI). 
2.) Snoring - yes/no 
A 4-point frequency scale was used to grade each question. Most questions were coded 
and loaded into SPSS® according to the scales 0 = frequently; 1 = 3-4 times a week; 2 = 
1 -2 times a week; 3 = 1-2 times a month and 4 = never or nearly never, or according to 0 





5.) Disturbance to others 
6.) Breath-holding 
Category 2: 
7.) Fatigue on awakening 
8.) Excessive daytime sleepiness (EDS) 
9.) Sleepiness whilst driving 
Category 3: 
10.) A history of high blood pressure 
Appropriate reversals of BQ questionnaire data were made. This was necessary to ensure 
that all questions were rated according to 0 = lowest value and 1/2/3/4 were incrementally 
the highest values. 
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A descriptive analysis was conducted to examine distributional characteristics and 
demographics of the sample. Cronbach a was used to examine reliability as a measure of 
internal consistency among individual questions within symptom categories (snoring, 
EDS, driving while sleepy and a history of high blood pressure). The Cronbach a ranges 
from 0 to 1.0 and reflects the extent to which the items are measuring the same thing. 
Pearson's Correlation coefficients was used to compare questionnaire responses to the 
HypnoPTT™ data. This analysis is a method of measuring a correlation between two 
quantitative variables that are related in a linear fashion. Multiple linear and multinomial 
regression analysis was applied to analyse the separate and joint influences of the BQ 
questions as the independent predictor variables on dependent variables. The AHI was 
considered the most robust dependent as well as snoring, lowest oxygen desaturation and 
ANA's according to international consensus (AASM Task Force report, 1999). 
The data was initially evaluated in terms of the patient's characteristics and 
demographics. Thereafter the BQ data was examined according to each question to 
evaluate the prevalence of symptoms and behaviour indicative of OS A. A brief synopsis 
of gender was made from the BQ data. Age matched gender comparisons could not be 
made due to the skewed proportion of males to females. From the BQ data, the 
physician's result was explored using a Pearson's correlation coefficient to ascertain 
whether the final report represented results in line with international consensus. 
All this information was then used to correlate subjective and objective data and 
formulate dependent and independent variables for stepwise linear and multinomial 
regression, which was then used to investigate the possibility of predictive relationships 
between BQ and HypnoPTT™ data. 
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This category analysis was computed in SPSS using equations to delineate each 
category. The computations can be viewed in Appendix H and is detailed in 4.6.4. under 
risk factor analysis. 
4.6.2. HypnoPTT™ data loading and analysis 
1. One hundred and nineteen (119) patients recorded all night sleep studies. 
2. The physician downloaded the data from the HypnoPTT™ after computerised 
analysis, which elicits categorical results from the data acquired. 
3. The physician then manually checked the raw data which can be viewed page by 
page, to confirm the accuracy of the computerised analysis. This is common 
practice in sleep laboratories - the computer often over or under scores events 
(Stevens, 2004; Personal communication, Dr. E. Ebrahim, London Sleep Centre, 
London, October, 2004; Dr. D. Hooper, Berea Sleep Laboratory, Durban, June, 
2006; Prof. V.K. Somers, Mayo Clinic Sleep Research Unit, Rochester, USA, 
June 2006). 
4. Data was saved to the main database and transferred to CD discs. 
The physician generated a report (loaded as physician result) based on his clinical 
impression, the results from the HypnoPTT™ recording and international criteria for 
diagnosing OSA (ibid). This report assessing the severity of OS A reflects two aspects 
regarded as critical by current sleep analysis standards (Chokroverty, 1999; Olsen et al, 
2003; Stevens, 2004; Personal communication, Dr. E. Ebrahim, London Sleep Centre, 
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London, June, 2006; Dr. D. Hooper, Berea Sleep Laboratory, Durban, June, 2006; Prof. 
V.K. Somers, Mayo Clinic Sleep Research Unit, Rochester, USA, June 2006, Table 4-1): 
a. The data recorded by the HypnoPTT™ device is perused with 
particular reference to physiological data and empirical evidence as 
noted. The AHI, the degree of oxygen desaturation, the level of snoring 
and ANA's are considered gold standard measurements. All these 
parameters are rated according to severity prior to loading. These 
ratings can be viewed in Table 4-1. for snoring, AHI and oxygen 
desaturation. 
b. The physician's clinical impression, supported by evidence as 
discussed above. 
The HypnoPTT™ data was divided up into results pertaining to the AHI, snoring 
behaviour, oxygen desaturation and ANA's according to severity ratings in the mild, 
moderate or severe range. 
4.6.3. Risk category analysis 
A risk factor analysis was made to categorise patients according to low and high risk in 
accordance with Netzer et al. (1999). Furthermore, these researchers showed that the 
high-risk group had an AHI >5. Sharma et al. (2006) also applied these categories to 
predict an AHI >5 for high-risk BQ cases. Cases from the current study were similarly 
rated. 
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In category 1, high risk was defined as persistent symptoms (>3-4 times a week) in two or 
more questions about their snoring or breath-holding behaviour. In category 2, high risk 
was defined as persistent symptoms (>3-4 times a week) waketime sleepiness, drowsy 
driving or both. In category 3, high risk was defined as a history of high blood pressure 
or a BMI more than 30 kg/m2. To be considered a high risk for OS A, a patient had to 
qualify for at least two categories. Those who denied having persistent symptoms or who 
qualified for only one symptom category were placed in lower risk (Netzer et al.1999). 
These category calculations are summarised in a framework in figure 4-1. 
A.Categorv 1 
Snoring - 3 Questions 
High risk = Qualify for 
at least 2 questions. 





Sleepiness - 3 Questions 
High risk = Qualify for 
waketime sleepiness, 
drowsy driving or both 




OSA= qualify for 2 categories 
A&B;B &C, A&C 
C.Categorv 3 
High blood pressure & 
BMI 
High risk = high BP or 
BMI > 30kg/m2 
i k 
Figure 4-1. Framework showing high and low risk category calculations according to 
Netzer et al. (1999). 
This category analysis was computed in SPSS using equations to delineate each 
category. Further analysis estimating the probability of an AHI>5 predicting the high-risk 
case was made using a multinomial logistic regression model (Appendix H). 
The multinomial model was used to account for the classification of more than two 
classes (the rating scales) and handle the AHI ratings as the dependent variable. 
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Table 4-1. Table showing the ratings for HypnoPTT™ variables according to 
physician rating and expert consensus. 
Total Snoring Oxygen saturation level AHI 




Dr. D. Hooper 
0. Normal - >96% 
1. Abnormal-<96% 
*Lowest O desat is 
used frequently 
Rechtchaffen & Kales, 1968 
0. <5 per hour - normal 
1. 5-20>-mild 
2. 20-30 - moderate 
3. >30-severe 
Stevens, 2004 
ANA's were rated according to events less than 14 per hour, which are considered within 
the normal range and events over 14 per hour, which are considered abnormal. 
BMI was divided into obese and not obese. A BMI >30 kg/m2 was considered obese in 
accordance with international clinical agreement. 
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CHAPTER 5. RESULTS 
Of the 124 patients seen in the sleep laboratory from June to November 2005,119 (N) 
patients were booked for HypnoPTT™ sleep studies and verbal consent obtained from 
the sleep physician to complete BQ's. Missing data was taken into account during 
analysis. The missing patients were excluded on the basis of inadequate or spoiled data 
acquired by the sleep system, and a few variables values, which did not record data 
during the night. Three (3) patients did not have successful studies and are therefore 
represented as "empty" cells in the data sheet. The remaining 116 and were entered for 
analysis. 
Patients completed the BQ subjective questionnaire prior to undertaking HypnoPTT™ 
overnight sleep studies. One hundred and ten (110) patients completed BQ. Nine (9) 
patients did not complete the BQ. Missing cells represent individual questions not filled 
in by subjects. Any extra missing objective HypnoPTT™ data represents individual 
variables not recorded by the device or questions left out by patients in the BQ subjective 
data because they did not know the answers or spoiled the response (e.g. ticked two boxes 
in one question). 
Summary of the number of patients participating in the study 
• N=119 
• HypnoPTT™ data: n = 116 (3 not completed - 2 recording failures, 1 
patient absconded) 
• BQ data: n = 110 (9 not completed) 
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Recording time ranged between 137 minutes and 719 minutes. The standard cut off time is 
less than 120 minutes therefore no studies were excluded on the basis of inadequate 
recording time. The average recording time was 445 minutes (approximately 7.5 hours). 
No patients chose the isiZulu translation - all patients completed the BQ in English. 
5.1. Patients and demographics 
This data is derived from the clinical intake and HypnoPTT™ data. 
The mean age was 46.9 years (range 21-78, SD - 11.3). 
The distribution of race shows a preponderance of white subjects (73 subjects - 61 %) 
followed by indian subjects (37 subjects - 31 %). There were 4 (3.4 %) black subjects and 
2 (1.7 %) coloured subjects. 
The following results are derived from the BQ questions (height and weight were verified 
by the physician). 
In response to biological data the following results are noted: 
BQ Question 1: 
Height: The mean height of the patients was 1.7 m 
(SD = . 10; Range 1.4 -1 .9 m). 
Weight. The mean weight of subjects was 98.2 kgs. 
(SD = 22.6, Range 54 -185). 
BMI: The mean BMI was 33.9 kg/m2 (Obese range). 
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5.2. BQ data - Prevalence of symptoms 
The following results are descriptive statistics from BQ data addressing each BQ question 
individually to examine the prevalence and severity of symptoms and behaviour. Each 
question was loaded into SPSS® in the same format as the questionnaire. The lowest 
score (0) represents the normal or low risk level and the highest score (3 or 4) the high 
risk level. 
5.2.1. Category 1 - Risk group; Questions 2 - 6 ; Snoring and breath-holding 
BQ Question 2 













Don't know No Yes 
Do you snore - BQ data 
Figure 5-1. BQ 2 results showing "do you snore?" data (Missing = 9). 
55 
BQ Question 3 
The majority of respondents reported high snoring volume: 79 (66.4%) reported that their 
snoring could be heard in adjacent rooms (Figure5-2). 
Slightly louder As loud as Louder than Very loud, 
than breathing talking - Low talking - High heard in 
-Low risk risk risk adjacent 
rooms - High 
Risk 
Your snoring is...volume of snoring BQ data 
Figure 5-2. BQ 3 results showing "your snoring is".. .volume of snoring data 
(Missings 10). 
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BQ Question 4 
For snoring frequency, 99 (83.2 %) patients reported snoring nearly every day (severe 
range) (Figure 5-3). 
1-2 times a week- 3-4 times a week - Nearly every day -
Low Risk High Risk High risk 
How often do you snore • BQ data 
Figure 5-3. BQ 4 results showing "how often do you snore" data (Missing = 10). 
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BQ Question 5 
Snoring bothers others, 106 (89.1 %) reported yes (Figure 5-4). 
No Yes 
Snoring bothers others -BQ data 
Figure 5-4. BQ 5 results showing "snoring bothers others" data (Missing = 9). 
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BQ Question 6 
In response to the question of others observing breath-holding events during sleep, 51 
(42.9%) breathing pauses were noted nearly every day (Figure 5-5). 20 missing entries 
are noted, 9 of which are missing data due to BQ's not being completed, the remaining 11 
represent non-responses from patients. These patients were unaccompanied by a partner 
and/or slept on their own - they simply did not know if they hold their breath during 
sleep. 
Never- 1-2Times 1-2Times 3-4Times Nearly 
Low risk a month - a week - a week - every day 
Low risk Low Risk High risk - High risk 
Breath holding during sleep 
Figure 5-5. BQ 6 results showing ".. .hold your breath" data (Missing = 20). 
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5.2.2. Category 2 - Risk group; Questions 7-9; Sleepiness factors 
BQ Question 7 
In response to questions regarding not feeling refreshed after sleep, 11 (64 %) patients 
complained of sleepiness on awakening (Figure 5-6). 
Never- 1-2 Times 
Low risk a month -
Low risk 
1-2 Times 3-4 Times Nearly 
a week - a week - every day 
Low Risk High risk - High risk 
How often are you tired or fatigued after 
your sleep- BQ data 
Figure 5-6. BQ 7 results showing "how often are you tired after sleep" data 
(Missing = 9). 
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BQ Question 8 
On the question regarding daytime sleepiness (EDS), 70 (58.8 %) respondents reported 
feeling sleepy nearly every day (Figure 5-7). 1 participant did not respond to this 
question. 
Never- 1-2Times 1-2Times 3-4Times Nearly 
Low risk a month - a week - a week- every day 
Low risk Low Risk High risk - High risk 
Excessive daytime sleepiness- BQ data 
Figure 5-7. BQ 8 results showing "during your wake-time do you feel tired" (EDS) data 
(Missing = 10) 
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BQ Question 9 
70 (58.8 %) Of the patients denied ever feeling sleepy whilst driving (Figure 5-8) and 13 
(10.9 %) were aware of sleepiness whilst driving. One subject did not complete this 
question. 
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Never - 1 -2 Times a 1 -2 Times a 3-4 Times a Nearly 
Low risk month- week- week- every day-
Low risk Low Risk High risk High risk 
Sleepiness whilst driving 
Figure 5-8. BQ results "ever nodded off while driving" (Missing = 10). 
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5.2.3. Category 3 - Risk group Questions 1 and 10, BMI and high blood pressure 
Question 1: Body Mass Index: 
Forty-eight (48, 40.3 %) of the patients have a BMI below 30kgs/m2 and 68 (57 %) had a 
BMI above 30kgs/m2 (Figure 5-9). 
BM!<30kg/m >30kgs/m 
BMI - PTT data 
Figure 5-9. BQ results showing the BMI data (Missing = 3) 
63 
Question 10 
On reports of a history of high blood pressure, 44 (37 %) patients reported a known 
history high blood pressure, and 66 (55%) either said they did not have a history or did 
not know they had suffered from high blood pressure (Figure 5-10). 
> 













Figure 5-10. BQ 10 showing results of "history of high blood pressure" (Missing = 9). 
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No - Low risk Yes - High risk 
High blood pressure-BQ data 
For efficient diagnostic purposes it is generally practice when using questionnaires to 
develop a total score and rate this scoring according to normal and abnormal scores with a 
cut-off range. For example the Epworth Sleepiness Score (ESS) (Appendix C) has a 
maximum score of 24. Scores over 11 are considered the cut-off for sleepiness, 16 and 
over are rated as moderate to high levels of sleepiness (Johns, 1991). The highest total 
score possible for the BQ is 28 points. Figure 5-11 shows the frequencies of the BQ total 
scores for patients in this sample. The mean total score was 21 (SD 4.4, Range 8 - 28). 
17 patients scored 23 points. Missing data is accounted by 9 full BQ's and any BQ's, 
which had empty questions (21). In other words if even one response was missing in the 
full set of questions, it was excluded. 
BQ Total Score 
Figure 5-11. Frequency hypnogram showing the total BQ score distribution 
(missing = 21). 
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5.3. BO - Gender, culture and risk factor considerations 
There are 93 (78%) males and 23 (19%) females in this sample. Statistical inferences 
were not possible because of the low number of females in the sample. Age-matched 
samples therefore could not be examined. The fact that this sample of patients from a 
clinical population has a high amount of males is significant in terms of historical and 
current empirical data quoting risk factors. Research consistently quotes high risk for 
OS A is the "middle aged male" (Chokroverty, 1999; Stevens, 2004). Descriptively, age 
distribution did not appear to be different between male and female groups: 
Males - Mean age 46.8; SD 11.5; Range 26-75 years. 
Females - Mean age 44.8; SD 13.6; Range 21-78 years. 
5.4. HypnoPTT™ data - Prevalence of symptoms and behaviour 
Heart rate was recorded throughout the night. The mean heart rate recorded was 70.1 
Beats per Minute (BPM) (Range 48 - 101, SD = 10.2). The mean minimum heart rate 
was 45.1 BPM (Range 45 - 26, SD = 8.9) and the maximum heart rate mean was 115 
BPM (Range 73-82, SD = 16.5). 
As a means of finding a specific criterion-based variable to assess criterion validity, the 
physician's result, which is largely based on a clinical impression, and supported by 
HypnoPTT ™ physiological data, was selected (detailed in Chapter 4. Methodology 
4.6.2). Empirical evidence consistently quantifies diagnostic protocols, which are 
particularly sensitive to the diagnosis of OS A (AASM Task force report, 1999). 
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Diagnostic criteria grades OSA into normal, mild, moderate and severe categories. This 
data was obtained from the physician's final report sent back to the referring physician. 
Analysis of the physician result shows 64 (42.7%) subjects fell into the severe range 
(Figure 5-12). Fairly equal distribution is noted between moderate and mild cases. Only 8 
patients fell into the normal range. 
OSA Moderate Severe OSA 
OSA 
Normal range 
Result -physician comment - PTT data 
Figure 5-12. HypnoPTT™ data showing the OSA severity ratings from the 
physician's final report (missing = 3) 
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5.4.1. Examining the criteria used in the physician's report 
As a starting point, it was deemed necessary to examine criterion validity in the 
physician's final report to verify results consist with current practice. The AHI is the most 
consistent variable used by most researchers. In addition the level of snoring, lowest 
oxygen saturation value and the total snoring value are consistently reliable variables 
(Stevens, 2004; AASM Task force report, 1999). Of late the use of ANA's is also being 
incorporated more often as a measure of sleep fragmentation, which is known to 
contribute to EDS. ANA's have therefore been included in the analysis (Stradling & 
Davies, 2004). Wolk et al. (2003) also link a BMI>30kg/m2 with OSA severity. 
Examination of the total AHI with the physician's result showed a strong relationship (r = 
.79,p < 0.01). Correlation with the ANA's was also fairly high (r = 0.58,/? < 0.01). 
Moderate correlations are noted between the physician's result and the lowest oxygen 
value (r = .57, p < 0.01). The BMI was significant, but with a modest correlation (r = 
0.25, p < 0.01). No significance is noted between the physician's report and snoring 
events (r = .05, p < 0.05) (Table 5-1.). 
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Table 5-1. Correlations showing the relationship between the physician's results 
and HypnoPTT™ variables used globally for OSA severity rating. 
(Missing = 3 PTT data, 5 ANA values not recorded) 
~& 
lowest 
sats ANA BMI 
707(**) .775(**) .279(**) 
572(**) .588(**) .245(**) 
116 111 116 
** Correlation is significant at the 0.01 level (2-tailed). 
5.4.2. AHI results recorded by HypnoPTT™ 
The severity of the AHI (calculated as the number of times per hour the subject held 
his/her breath) from the physiological data recorded, showed the majority of patients were 
in either the mild, moderate or severe range (35, 29.4%) (Figure 5-13). 






Total Result - Snoring 
1 .787(**) .028 
787(**) 1 -.049 
116 116 116 
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< 5 - Normal 5 - 20 - Mild >20 - 30 - >30 - Severe 
range range Moderate range 
range 
Total AHI 
Figure 5-13. AHI severity ratings recorded by HypnoPTT™ (missing = 3). 
The AHI showed significant correlations with the ANA's (r =0.78, p <0.01), the lowest 
oxygen value (r = .70, p <0.01) and mild significance with the BMI (r = .28,/? <0.01) 
(Figure 5-1). A full table of the correlation values are displayed in Appendix I. 
5.4.3. Lowest oxygen saturation recorded by HypnoPTT 
The mean low oxygen saturation recorded was 78.7 % (Range 49 -97, SD - 12.1). The 
majority of patients cluster between saturations of 85% to 95% through the night. 
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However 21 patients reached levels of < 60%. Figure 5-14 shows the frequency of 
oxygen percentage values recorded across the night. 
Mean =78.66 
Std. Dev. =12.123 
N=116 
50 60 70 80 90 100 
Oxygen desaturation lowest -percentage PTT data 
Figure 5-14. Hypnogram showing the lowest oxygen saturation values recorded the 
HypnoPTT™ (missing = 3). 
5.4.4. Severity of snoring recorded by HvpnoPTT TM 
Objective data indicated that in a large majority of subjects, excessive snoring occurred. 
Snoring was severe in most subjects (104; 8.7.48%) (Figure 5-15). 
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< 20 total 20-100 total 100-300 total > 300 total 
snores snores snores snores 
Snoring - total number of snores -PTT data 
Figure 5-15. Severity of snoring recorded by HypnoPTT™ (Missing data = 3). 
5.4.5. Autonomic arousals (ANA's) recorded by HypnoPTT 
ANA's were graded according to events greater or less than 14 micro-arousals suggestive 
of sleep fragmentation. The majority of patients fell into the >14 range (111, 93%), which 
international criteria suggests falls within the abnormal range. 
The ANA values were not recorded on 5 subjects. The number of arousals during the 
night ranged between 15 and 140 with the majority of subjects experiencing 
approximately 30-70 arousals during the night. Figure 5-16 shows the frequency of 
ANA's occurring across the night. 
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Figure 5-16. Histogram showing the frequency of ANA's across the night 
(Missing = 5). 
5.5. Construct validity - Comparison of objective and subjective data 
The validity of the BQ in this South African clinical population will be explored in this 
section. As discussed in the methodology, the BQ was originally the outcome of a the 
conference on Sleep and Primary Care involving the integration of clinical input from 120 
US and German pulmonary and primary care physicians to simplify recognition of OS A. 
Whilst the questionnaire is undergoing validation in Europe and USA by various authors 
(in progress) it was highly recommended by the Mayo Clinic group researching sleep 
disorders as part of their screening procedure (Personal communication, Prof. V.K. 
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Somers, Director, Mayo Clinic Sleep Research Unit, Rochester, USA, October 2004, 
February 2005). 
Whilst a brief discussion on validity measures will be explored, the main focus this study 
is on construct validity. 
5.5.1. Validity assessment 
5.5.1.1. Face validity 
There is current empirical evidence in other populations that the BQ represents sound 
clinical criteria consistent with OSA symptoms, risk factors and consequences, 
particularly when risk factors are divided into symptom categories separating high and 
low risk subjects (Netzer et al. 1999; Stevens, 2004). 
The categories address: 
1.) Snoring 
2.) EDS, driving or both and 
3.) High blood pressure or a BMI > 30g/kg 2. 
At a glance, the questions in particular clearly address factors, which consistently focus 
on commonly known symptoms such as breath-holding during sleep, risk factors such as 
gender, a history of high blood pressure and BMI and behaviours such as snoring and 
sleepiness during the day and whilst driving. 
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In this population however, consistent difficulty understanding Americanisms such as 
"quit" or "not up to par" may have caused subjects not to complete those particular 
questions. 
5.5.1.2. Reliability and predictive validity 
The reliability amongst individual questions within symptom categories was explored as a 
measure of internal consistency. The Cronbach a value was 0.62 for all BQ questions. 
All snoring and breath-holding questions which include "snoring volume"; "snoring 
frequency"; "snoring bothering others" and "breath-holding during sleep" (category 1) 
showed a Cronbach a value of 0.40. 
Questions on sleepiness - "tired after sleep", "tired during wakefulness" and "sleepiness 
whilst driving" (category 2) produced a Cronbach a of 0.68. Consistent with Netzer et al. 
(1999), when sleepiness behind the wheel was excluded, the Cronbach a went up to 0.84 
in category 2. 
On questions regarding high blood pressure and BMI (category 3) with the Cronbach a at 
0.18, are not reliable. 
(Additional statistical information is available in Appendix G). 
5.5.1.3. Construct validity 
Construct validity was examined by correlating HypnoPTT™ data and the BQ questions 
1-10. Furthermore, a stepwise multiple regression analysis model was created in order to 
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examine the predictive influence of dependent variables from the HypnoPTT™ data on 
the BQ questions 1-10. A "total BQ" score was created as a variable against which the 
physician's result was cross-tabulated. The highest total score possible for the BQ was 
calculated as 28. (Results can be viewed in Figure 5-11). 
As mentioned, the AHI index was a particularly robust variable in this study. The lowest 
oxygen saturation value, snoring and ANA's are frequently used to predict the presence 
of OSA. These variables were used as the framework for statistical analysis. No 
significant correlations or predictive measures were found using the total AHI or linear 
regressions on individual BQ questions against the selected criteria as the independent 
variables. The total BQ score however showed a moderate and significant correlation 
with the lowest oxygen saturation level (r = 0.42, p <0.01), the physician's final result (r 
= 0.24, p <0.05) and the AHI total (r = 0.21, p = 0.05) (Table 5-2). 
Table 5-2. Table showing correlations between the total BQ score and PTT 
variables. (Missing = BQ - 21, PTT - 3, total missing = 24). 
PTT PTT 
AHI Total 02 Low 
.206(*) -.415(**) 
95 95 











5.6. Risk factor category analysis 
A risk factor analysis was made to categorise patients according to low and high risk by 
computing the possibilities and creating separate variables in SPSS . Firstly, each 
category was calculated (snoring, sleepiness and high blood pressure and BMI > 
30kg/m ). Secondly, after the final high-risk case group was computed (Case BQ), which 
was a combination of the three categories in various combinations (Netzer et al. 1999) 
(detailed in methodology Chapter 4, Table 3-1 and Appendix H) a multiple logistic 
regression was used to estimate the probability of an AHI >5 predicting the high risk 
group. The missing data is accounted for by 9 omitted BQ's and 2 BQ's with too many 
empty cells to qualify as a case. The following results are noted (the pie graphs can be 
viewed on the next page). Multinomial regression analysis was also used to refine the 
possible significance of the AHI to predict high-risk cases using the AHI rating criteria. 
In category 1 for snoring, 97 (81.5 %) patients qualify as high-risk cases for snoring 
symptoms (Figure 5-17). 
For category 2, 69 (58%) patients were at high risk for sleepiness symptoms 
(Figure 5-18). 
Category 3 high-risk analysis shows only 17 (14.3%) patients qualified as high risk 






Figure 5-17. Pie graph showing risk category 1 - Snoring parameters 
Figure 5-18. Pie graph showing risk category 2 - sleepiness parameters 
Figure 5-19. Pie graph showing risk category 3 - High blood pressure and BMI > 
30kg/m parameters. 
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In the various combinations - qualifying for any two combinations of the high risk 
categories, 71 (73.1%) patients qualified as high-risk and 37 (31.1%) as low-risk cases for 
the presence of OSA with an AHI > 5 (CaseBQ) (Figure 5-20). 
I ^ H Low risk -
Is not a case 
I High risk -
Is a Case 
Missing 
Figure 5-20. Pie graph showing high-risk category combinations = CaseBQ. 
5.6.1. Using high risk cases to predict an AHI >5 
The high-risk category was computed to predict an AHI >5. This analysis shows that 70 




Figure 5-21. Pie graph showing high-risk cases qualifying for an AHI >5. 
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5.6.2. Using the AHI ratings to refine prediction of BQ high risk category 
A multinomial regression analysis was used to test the BQ (variable 'CaseBQ)' as a 
predictor of the AHI ratings classification (<5, 5-20, 20-30 and >30 per hour). This 
analysis was made in order to examine the sensitivity of the BQ to identify patients in the 
normal, mild, moderate and severe range of OS A. 
Test of the overall model-AHI (Dependent); CaseBQ (Covariate) 
The Likelihood ratio and model chi-squared test (goodness of fit) analysis reflects the 
significance of unexplained variance in the AHI ratings (dependent variable). The 
AHI/CaseBQ model does not appear to be a good one, since the difference between the 
two ratios in the model increase in magnitude (one would expect them to decrease in a 
good model) (2LL = 22.17; 2LL = 35.55). Furthermore, this model is less than 0.05 (r 
=13.3;p = 0.004). One would expect a well-fitting model to be significant at the 0.05 
level or better and a model shows a 'goodness of fit' when the chi-squared is not 
significant. 
The standard error in the Wald statistics (parameter estimates — Table 5-3) of this model 
is inflated (Normal range SE = .569; moderate range SE = .810) suggesting Type II errors 
(false-negatives -thinking that the effect is not significant when it is). 
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Summary: The overall significance of the AHI/CaseBQ model should be viewed 
with caution, however based on the possible significant effect of this model to identify 
high-risk cases we cannot simply reject the findings of this model because many cases 
may been identified as false-negatives, when they were indeed cases. The parameter 
estimates and classification of cases indicates that the BQ is a reasonably sensitive 
predictor of cases in the mild range (57.1%) and severe range (80.6%) (Table 5-4). 
Table 5-3. Table showing parameter estimates using the AHI rating scores and the 





























a.The reference category is: >30 - Severe range. Dependent BQ = 0 
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Table 5-4. Table showing predicted high-risk cases for OSA using the AHI rating 


















































The reference category is: >30 — severe range. 
The fact that the use of separate high-risk category analysis may be a more sensitive AHI 
predictor was considered. A multinomial regression using AHI ratings and each category 
(cat) for snoring, sleepiness and BP + BMI, was therefore constructed. 
Test of the overall model-AHI (Dependent) 
Cat 1-snoring; Cat 2-sleepiness; Cat 3-BP+BMI (Covariates) 
Likelihood ratio and model chi-squared test (goodness of fit) analysis shows that the 
category analysis combination is a well fitting model. 
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The difference between the two ratios in the model decrease in magnitude as one would 
expect (2LL = 60.40; 2LL = 41.39). Furthermore, this model is greater than 0.05 (r 
=19.0; p = .025). This model shows a 'goodness of fit' because the chi-squared is not 
significant O = 6.50; p = .369). 
Cat 1 - Snoring: r = .903;p = .825 
Cat 2 - Sleepiness: r = .12.24; p = .007 * 
Cat 3 - BMI>30 Kg/m2 + High blood pressure: r = .4.34; p = .226 
(*Type II error possibility - assumes overall good model fit) 
Standard error in the Wald statistics of this model is also mildly inflated (Table - 5-5), 
which suggests possible Type II inaccuracies. 
Summary: The overall significance of the AHI/Category analysis model is a far more 
reliable measure of the sensitivity of the AHI ratings to predict the high-risk patient for 
OSA. The parameters estimates for snoring, sleepiness and BP+BMI are more refined 
showing sensitivity of the AHI to cases in the normal range (54.3% - AHI <5), the mild 
range (64.5% - AHI 5-20), and 25.8% in the severe range (AHI >30). Cases in the 
moderate range were not significant in this model. It seems that this model is more 
capable of refining the case recognition to include the mild cases. Interestingly, neither 
model is sensitive to cases in the moderate range (20-30). From a symptom point of view, 
snoring and BMI/BP symptoms seem to be more accurate reflections of the presence of 
OSA, in other words the significance values >0.05. 
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Table 5-5. Table showing parameter estimates using the AHI rating scores and the 
























































The reference category is: >30 - Severe range. 
Table 5-6. Classification table showing predicted high-risk cases for OSA using the AHI 
ratings and the high-risk categories - snoring, sleepiness and BP/BMI. 
Observed 

















































Summary: The overall significance of this model for diagnostic purposes is far more 
reliable (and therefore valid) measure than using the CaseBQ model. In other words the 
symptom categorization model using symptoms of snoring, sleepiness and BMI/BP refines 
case recognition more accurately. The parameters estimates and classification of cases 
indicate that in this model the BQ high-risk symptom categories are capable of identifying 
54% of the cases in the normal range 0-5, which is effectively the low risk group. In the 
mild range (5-20) - a high-risk group, the case recognition rate is 64%. This model did 
not identify any cases in the moderate range but identified 26% of severe AHI range - >30 
high-risk cases (Table 5-3) (Appendix K). 
5.6.3. Validity and diagnostic significance of risk factor analysis findings -
examining the hypotheses 
For the patient to be considered high-risk, he/she experiences symptoms 3-4 times a week 
or more. The symptoms categories identified in this study are: 
• Snoring (81 % = high risk) 
• Sleepiness factors, which include feeling unrefreshed on awakening, 
daytime sleepiness and sleepiness at the wheel (58% = high risk) 
• BMI > 30kg/m2 and high blood pressure (14% = high risk) 
The high-risk (Case BQ) group consolidates these symptoms by selecting patients based 
on whether they experience at least two of these symptom categories. 
The sample examined in this study is a clinical population with 60 % of the cases 
qualifying as high-risk for OS A (CaseBQ group). In comparison Netzer et al (1999) 
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identified 37.5% in a primary health care USA out patient population at high-risk for 
OSA. Similarly Sharma et al. (2006) identified 44% as high-risk cases in an Indian 
primary health care out patient sample. 
Internal consistency is reasonably demonstrated by a Cronbach a of 0.62 for all questions, 
and went up to 0.84 for sleepiness questions, excluding sleepiness behind the wheel. The 
comparison of the BQ (subjective) and objective sleep study findings, or construct 
validity suggests that the BQ is a valid instrument to identify symptoms that are 
considered diagnostic indicators in this clinical sample. Firstly, criterion validity is 
confirmed by the questions in the BQ correlating with the lowest oxygen value (r = 0.415, 
p = 0.01), the physician's result (r = 0.242, p = 0.05) and the AHI total (r = 0.206, p = 
0.05). These parameters are all internationally recognized protocols for diagnosing OSA. 
The strength of this relationship is moderate however, suggesting that one cannot simply 
infer the presence of OSA by using the BQ in a primary health care setting at face value, 
for example by using a total score to diagnose the absence or presence of OSA. The 
questions as stated in the hypotheses then arise: 
1. Can the BQ be considered useful at all in South African clinical scenarios 
as a screening and/or diagnostic instrument? 
2. Does it have any predictive value? In other words, what is the probability 
that the BQ can identify cases with an AHI >5, or even ratings of the AHI 
from normal to severe? 
In the light of categorizing the risk factors, symptoms and behaviour of OSA it seems that 
there is some value to be realized in using the BQ in a clinical setting. 
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The CaseBQ - high-risk group identified 60% of the patients with an AHI>5, which is 
considered moving into the abnormal range, or the range beginning to indicate the 
presence of OS A. Furthermore, broadly speaking, if in a model using the high-risk group 
(the CaseBQ model), the BQ can predict more than half (57%) of cases with an AHI <5 
rating, effectively those patients who for argument's sake were referred with symptoms of 
snoring and sleepiness but did not present with specific OSA symptoms, and also predict 
up to 81% of the 'severe' cases, who may indeed have significant OSA symptoms, then it 
follows that this questionnaire may be valuable as an adjunct screening tool and 
'symptom' diagnostic instrument in clinical settings. Statistically however, this model is 
unstable and may be misleading. 
Statistically then, a more realistic and valid construct is found in the model using the 
symptom categories in combination. It seems that this model is able to refine the 81 % 
case recognition in the severe range for the first model. To suggest that the BQ is able to 
identify 65% of the cases with a mild AHI rating and 26% of the cases in the severe AHI 
rating group, gathers support for hypothesis that the BQ can indeed be used in South 
African clinical health care facilities to differentiate patients with risk factors for OSA by 
quantifying symptoms such as snoring, sleepiness factors and BP/BMI, in line with 
international consensus. The snoring and PB/BMI have greater strength for diagnostic 
purposes that the sleepiness factors in this study, however the research investigated 
consistently shows that excessive daytime sleepiness is a strong indicator of the presence 
of OSA and simply fragmented sleep, which is also linked to numerous other sleep 
disorders. 
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It is clear however, that the clinical impression and the ability to identify high risk factors 
such as obesity (BMI>30kg/m2) and a history of high blood pressure, to recognize high-
risk behaviour such as excessive snoring, breath-holding during sleep and a variety of 
sleepiness factors remains the most important diagnostic indicator. The importance of 
making an accurate diagnosis based on clinical findings, the symptomatic problems 
presented, collateral information and PSG investigation remains paramount. The BQ has 
some utility as an instrument to refine clinical intake and plan management. 
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CHAPTER 6. DISCUSSION 
6.1. Demographics and BO findings 
Descriptively, this clinical sample is a comprised predominantly of middle aged white 
and indian males. The average height of patients is 1.7m and a BMIkg/mg2 of 33 kgs was 
reported, which is considered obese. Gender differences could not be explored due to the 
skewed sample. Increasingly research shows that women are under diagnosed and treated 
(Gibson, 2005). Interestingly, the research on obesity in this country from a sample of 13 
000 men and woman >15 years old, reports that 29% of the men and 56.6% of women are 
obese. The obesity levels increased with age, and higher levels were found in urban 
African women (Puoane et al. 2002; Crowther and Pi-Sunyer, 2001). With the 
identification that OSA and obesity coexist (Wolk et al. 2003), it is apparent that at a 
public health care level, this syndrome requires our immediate attention. The current 
study leaves one with the impression that we have not even exposed the tip of the iceberg 
in the clinical health care forum. The psychological impact of obesity alone is profound; 
the added problem of not breathing adequately at night and the cascading consequences 
of OSA needs professional and specialised clinical management. Clinical health 
psychology is positioned ideally at a primary, tertiary level to investigate and develop 
policy for this syndrome. 
Snoring (BQ data), which impacts on the individual and others on a daily basis, is 
experienced by a high proportion of the sample (81%). They also frequently have 
symptoms of breath holding and sleepiness in the form of not feeling refreshed on 
awakening and daytime sleepiness (58%). Many patients reported not frequently 
89 
experiencing sleepiness whilst driving. In the face of their severe subjective ratings of the 
other sleepiness questions, the latter is an interesting finding which raises the question of 
whether the participants were rather wary of reporting this question honestly, or that they 
over-reported other sleepiness questions. Empirical data suggests that subjects are 
reluctant to report sleepiness whilst driving for fear of restriction on driving or loss of 
driver's licence (Rosenthal, 2005). Subjectively, these patients reported symptoms and 
behaviour, which falls into a high-risk category. 
A BMI >30kg/m2 and a history of high blood pressure were reported by 57% of the 
subjects. Many of these patients expressed "not knowing" whether they qualified for 
these symptoms or not, the findings could therefore have been over or under reported. 
Nevertheless, if extrapolated to the general population in South Africa this figure suggests 
that just over half of a clinical population (in other words patients referred to specialist 
facilities for suspected OSA, or high-risk symptoms) could be suffering with an elevated 
BMI in the obese range and a history of high blood pressure. The impact on the 
biopsychosocial and economic areas is profound, not only in terms of mental health but 
prescription medication as well. 
6.2. HypnoPTT™ findings 
From the final analysis of the HypnoPTT™ objective findings, the average heart was not 
used for analysis. The physician's result proved to be a reliable indicator of the severity 
ratings from the HypnoPTT™ data. The AHI showed an equal distribution of patients not 
experiencing breath-holding to those experiencing breath-holding within the mild and 
severe range. Only 11 patients fell within the moderate range. The AHI in line with 
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empirical data showed the most robust correlations with the physician's final report (r = 
.19, p < 0.01). ANA's were also significant markers of the final report outcomes (r = .76, 
p < 0.01). In addition the lowest oxygen saturation level was also significant (r = .71, p < 
0.01). An AHI of >5 events per hour is considered abnormal in some countries, whist 
others start 10. Only 35 patients in this sample do not fall within the abnormal range, 
which suggests that most patients in this sample will suffer the consequences of OS A if 
not treated. Whilst the cohort of this study will benefit from treatment, those in lower 
socio-economic brackets may not, unless policy changes. According to the literature 
reviewed, the sort of risk factors we could expect particularly in the severe range of 
untreated patients, would be obesity, male gender, upper airway abnormalities, cardio-
vascular (particularly hypertension) and pulmonary disease, genetic predisposition. 
Symptoms such as headache, anxiety, depression, sexual dysfunction, cognitive 
impairment, reduction of grey matter in the brain, frontal lobe deficits and performance 
degradation, may be the presenting problems. This daunting list provides the way 
forward for well-supported argument regarding the impact of these risk factors and 
symptoms on the individual, family, occupation and community. The cost to self and 
state will be enormous in the untreated patients. This could be extrapolated to the number 
of subjects who have not been identified. No epidemiology studies have been documented 
in South Africa to give us an indication of the extent of the problem. 
Prolonged oximetry recordings shows that the lowest oxygen saturation level mean for 
the sample was 78% with a range of 49-97%. This effectively means that the majority of 
patients saturated as low as 85-90% and in 20 patients levels fell below 60%. According 
to Stevens (2004) all these levels are considered low for basic physiological function and 
the critically low and/or fluctuation of oxygen levels may suggest the presence of 
91 
Cheyne-Stokes (noted in the late stages of cardio-vascular disease) or periodic breathing. 
This finding suggests that this sample of patients is at high risk for physiological deficits 
such as frequent autonomic arousals when the medulla is activated by fluctuating 
gaseous exchange (Somers, 2004). Furthermore sympathetic nervous system function is 
also alerted causing symptoms such as frequent urination. In addition, metabolic function 
is undermined (Ibid). 
Excessive snoring and ANA's were recorded in most patients. The majority of patients 
experienced between 30-70 autonomic arousals during the sleep recording. This 
extrapolates to extreme restlessness and sleep fragmentation. Stradling & Davies (2004) 
define sleep fragmentation as follows. The presence of snoring increased upper airway 
resistance and resultant rise in inspiratory effort, which in turn causes recurrent micro-
arousals - even without evidence of apnoea, hypopnoeas or hypoxia (upper airway 
resistance syndrome). Apnoea increases resistance to the level of prolonged partial and 
full arousals from sleep. The pattern of breath-holding, inspiratory effort and awakening 
is cyclical and persistent throughout the night. Martin (1997) produced some evidence 
that one night of sleep fragmentation and 'autonomic arousals' can have small effects on 
daytime function. The ability to measure daytime function (apart from the ESS) is 
disappointing but is gaining momentum, however the measurement of performance in a 
sleepy individual clearly shows decrements after fragmented sleep or prolonged sleep 
debt. The sample studied in this research are clearly at risk in terms of the profound sleep 
fragmentation experienced and the subsequent consequences that may ensue. The 
greatest concern lies with feeling sleepy whilst driving, which impacts on self and others. 
Micro-sleeps and early onset sleep can lead to motor vehicle accidents (Brown, 1994; 
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Dinges, 1995; Harrison and Home, 1996; Thorpy, 2005). Productivity is also affected, 
impacting on the social and occupational aspect of the patient's life (Rosekind, 2005). 
6.3. Validity and reliability findings 
A committee of experts gathered to discuss OS A originally designed the BQ. This group 
also oversaw the methodology and validation of the instrument. In particular the 
instrument focused on known risk factors for sleep apnoea. The purpose was to simplify 
the recognition of OSA. The BQ was validated in an American population. Whilst the 
content of the expert opinions is valued, it is well documented that psychological 
assessment instruments cannot simply be applied to any population on this basis; they 
need to be tested in other population for many important reasons such as language, 
culture and education. This study examined the construct validity of the BQ in a South 
African population. While the study focused on the construct of objective versus 
subjective findings, face validity, reliability, criterion validity, predictive validity and 
concurrent validity (the behaviour of this sample in relation to expected findings) were 
also examined. In particular the validation of the BQ was expected to bring about a 
means to increase efficiency, economy, practicality and fairness in a decision-making 
process for the promotion of making the right diagnosis when OSA is the underlying 
problem. In the clinical psychology forum it was hoped that the focus will be on the 
promotion of health and quality of life for patients. We expected to find a reasonable 
construct as the foundation for future clinical practice. 
No significant correlations were found between objective and subjective data using 
individual BQ questions. Internal consistency using Cronbach a correlations showed 
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values in an average to poor reliability range, with the exception of the sleepiness 
parameters. Sleepiness items showed mild reliability (0.68), particularly if sleepiness 
whilst driving was removed (0.84). All BQ questions lowered the reliability (0.62). 
Snoring questions were particularly poor (0.40). These findings are not as sensitive as 
current research suggests (range 0.68 - 0.84). Netzer et al. (1999) calculated a Cronbach 
a of 0.86 - 0.92 and Sharma et al. (2006) quotes an alpha value of 0.92 - 0.96. The 
reason for these findings may be three fold. Firstly, this sample of patients may have 
overstated their problem due to psychological distress (a cry for help or exaggeration of 
symptoms due to consequences of OSA, particularly those in the severe range). Secondly 
they may not have spent enough time thinking about responses in the presence of the 
physician. They may have experienced feelings of self-consciousness and time urgency. 
Thirdly, it is likely that many patients simply did not know how to rate their symptoms 
without the presence of a co-habiting partner or family member. A glance at the bar 
graphs rating frequencies of breath-holding events and the AHI, which is effectively the 
objective measurement for this parameter, illustrates visually the inability of the patients 
to categorically rate breath-holding events (Appendix K). 
Criterion validity was found to be adequate using the physician's result as a marker for 
frequently used criteria used to assess OSA (AASM Task Force Report (1999). The 
physician's result showed significant correlations with the AHI (r = .79,p < 0.01); 
ANA's (r = .59, p < 0.01); the lowest oxygen saturation level (r = .57,p < 0.01) and the 
BMI (r = .25, p < 0.01). These validity measures however cannot be extrapolated to the 
BQ on the basis of individual question as no consistent correlations were found between 
the physician's result and any singular BQ parameters. A weak relationship was found 
with history of high blood pressure ratings (r == 0.20, p <0.05)(Appendix G), which is an 
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unexpected finding in terms of current empirical data. However, in support of 
contemporary research data this study shows that when using risk factor analysis and a 
multinomial regression model, the findings indicates that the predictive value of the 
BP/BMI combination is stronger than sleepiness factors. 
Construct validity of the BQ however is supported by the correlation of the total BQ score 
and objective data. A moderate and significance correlation was noted between the BQ 
score and the lowest oxygen saturation level (r = -.42, p <0.01). The physician's result (r 
= .21, p < 0.05) and the AHI total (r = .21, p < 0.05) also showed significant correlation. 
6.4. Risk factor analysis findings 
The computation of risk factors shows that 81% of the sample qualifies for a high risk for 
reported symptoms of snoring. On questions regarding sleepiness 58% of the sample 
report symptoms of sleepiness in at least two questions on sleepiness and qualify as high 
risk. A history of high blood pressure and/or a BMI >30kg/m2 showed only 14.3% of the 
sample qualifying as high risk. Thereafter, to assess overall high risk in this sample, these 
categories were combined. Patients with persistent and frequent symptoms in any two of 
these three categories were considered at high risk for apnoea. 59.7% of the sample 
qualified as high risk for OS A. Being in the high-risk group predicted an AHI of >5 in 
68%o of the patients. Using AHI ratings refined the analysis even further. Using the 
categorisation of the AHI suggests that 65% of the high-risk cases were identified in the 
severe range (p = 0.001) and 35% in the normal range (p = 0.003). It would seem that the 
BQ is a valid tool to diagnose OSA if symptoms and risk category analysis is used. 
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6.5. Implication of findings 
The validity of the BQ was explored by Netzer et al. (1999) they did not contend that the 
BQ was simply a valid tool for diagnosis of OS A. They proposed that the BQ "provides a 
means of identifying patients who are likely to have sleep apnoea" (p.485). Sharma et al. 
(2006) conclude that the BQ "can identify high risk subject and thus avoid unnecessary 
[PSG] studies especially in resource-limited settings" (p.281). Similarly, but with far less 
robust findings, this study shows that whilst BQ individual questions and even 
categorized data do not show significant enough validity and internal consistency to use 
as a pure diagnostic tool at all, it seems that in this clinical sample at least half of the high 
risk cases are identified by an AHI >5, particularly in the high risk group. This suggests 
then that if the BQ is to be useful in clinical settings, it should be approached with caution 
in terms of simply using it to diagnose and treat OSA patients. It remains to be seen 
whether the findings would change in a large cohort in the general population or in 
community primary health care facilities. 
Currently, the clinician would therefore not simply be looking for high total scores on the 
BQ and simply administer the questionnaire as a stand-alone diagnostic tool, but may 
guardedly apply the questionnaire adjunct to a good history, his/her clinical impression 
and the problem the patient brings. The clinician should be alert to symptoms and risk 
factors for OSA. The value of making the right diagnosis is paramount. Furthermore the 
clinical health psychologist should empower patients by protecting them from disease and 
promoting health. Educating and training other clinicians and the public is important, 
with a focus on health, not disease. The clinical health psychology paradigm requires 
disease centred protocols but health focused treatment and management interventions. 
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This approach in turn affects outcomes which no only impact on the individual, but on 
ecological systems, communities and policy reforms (Bronfenbrenner, 1979; Petersen, 
2004). 
Future research should focus on formulating a stepwise theoretical approach to addressing 
changing mental health policies for OS A which include a matrix of risk factors such as 
obesity and hypertension (Bickman, 2000; Chokroverty, 2004; Gibson, 2005; Gorin and 
Arnold, 1998; Naidoo and Wills, 2000; Petersen, n.d., 2000, 2004; Shamsuzzaman et al. 
2003); Somers, 2004; Shimura et al. 2005; Veglio, 2005; WHO, 1986;Wolk et al. 2003; 
6.6. Limitations of the current study and recommendations for future research 
The limitations of this research warrant discussion and provide a framework for the way 
forward, particularly for future research. 
(1) The study was conducted in a private clinical laboratory over ten months, which 
imposed constraints on the nature sample size and demographics of the cohort. The 
sample was skewed in terms of race and gender rendering inferences involving these 
parameters ineffectual. A pure clinical sample does however have the added advantage 
in this study of providing a "ready-made" high-risk group with which to compare the BQ. 
Future research in South Africa should be conducted in a research laboratory setting at a 
primary health care level using a larger sample from a geographically representative 
South African population. Epidemiology studies on the prevalence of OS A are also 
recommended. The BQ (including the isiZulu version in KwaZulu-Natal) could be useful 
for this endeavor (Katzenellenbogen, Joubert and Karim, 1997). 
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(2) The patients studied were a convenience sample referred from private physicians to a 
specialist physician in an elite private sleep laboratory catering for patients within a high 
socio-economic bracket, which cannot be considered to represent a cross-section of the 
South African population. Furthermore, this restricted the use of a control group for 
stronger inferences to be made. With these points in mind, all the conclusions reached 
must be considered specific to this sample and not generalised. Future research should 
focus on methodology capable of gender and age-matched samples. 
(3) The objective sleep study measure used - the HypnoPTT™ device, is a cardio-
respiratory screening device which was used in a home-based setting. The patients set up 
and monitored their own studies. The objective data therefore is not considered "gold 
standard" research data by international standards. The argument for home based studies 
however is strong as it helps to eliminate "first night effect" as the study in done in the 
patient's familiar environment. Moreover this technique involves the patient personally 
in his/her diagnosis and management. Increasingly, portable sleep studies are proving to 
be reliable, cost-effective and convenient units for diagnosing sleep apnoea and may 
certainly prove to be the way forward in primary health care facilities in South Africa 
where resources are limited and health promotion strategies need refining (Personal 
communication, Dr.D. Hooper, Berea Sleep Laboratory, January, 2006; Stradling et al. 
2002; Stradling and Davies, 2004; Petersen, 2000, 2004; Foster et al. 1997; Keleher, 
2001; Naidoo and Wills, 2000). Lastly, the methodology employed did not require full 
PSG protocols. 
(4) The strong relationships with the AHI should be used conservatively in clinical 
practice due to intraindividual variability of the AHI in consecutive and follow-up studies 
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(Hein & Magnussen (1999). In defence however, the AHI scores were graded into mild, 
moderate and severe for most of the statistical analysis and other researchers consistently 
find the readings to fall within these categories (Stevens, 2004). The full and rated scores 
were used to investigate risk category groups. Future study in research facilities should 
consider a second or third sleep study to compare AHI findings. 
(5) The most striking limitation to this study is the fact that sleep disorders are relatively 
untouched in this country in terms of relevant facilities for the general population and 
published research. Grants in the future should focus on assisting researchers who are 
investigating sleep disorders, in particular - OS A. The researcher of this study attempted 
to work with patients at a primary health care facility but it was not possible. This study 
us considered a pilot study for the way forward to further explore the validity of the BQ 
and conduct epidemiology studies. 
6.7. Conclusion and recommendations 
To address the aim, hypotheses and research questions of this study set out in Chapter 1, 
the following conclusions are reached: 
(1) The BQ is not a valid and reliable stand-alone instrument for diagnosing OS A. No 
objective items showed correlation or predictive relationship with individual BQ items 
data. Cronbach °c correlations showed values in an average to poor reliability range. 
Sleepiness items showed mild reliability (.68), particularly if sleepiness whilst driving 
was removed (.84). The strength of the validity of this questionnaire lies in the 
categorization of risk factors and the accumulative value of the BQ questions. Category 
analysis of high-risk groups, using the AHI as dependent variable identified 60% of the 
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high-risk cases. The total BQ score correlated adequately with the lowest oxygen 
desaturation value (r = -0.42, p < 0.01). Mild correlations were also found with the 
physician's result (r = 0.25,p< 0.05), and the AHI total (r = 02l,p< 0.05). All these 
variables are included as international protocols for diagnosing OSA. The overall 
sensitivity of the BQ to diagnose OSA with an AHI >5 was 59%, which is lower than 
Western studies. 
(2) The BQ should be used guardedly as a diagnostic tool. It's usefulness lies in the 
ability to differentiate high risk from low risk cases, particularly using symptoms of 
daytime sleepiness and risk factors such as a high BMI and a history of high blood 
pressure, which should lead to further clinical and objective investigation. In poorly 
resourced primary health care facilities the BQ may be useful as an adjunct diagnostic 
instrument to identify clusters of symptoms indicative of the syndrome. This procedure 
may assist primary health care clinicians to avoid unnecessary investigation in low-risk 
patients and refine diagnosis, treatment and management in high-risk patients. This study 
highlights that fact that clinical practice remains the arena in which OSA should be 
recognized, diagnosed and treated. Accurate diagnosis is the key to good management. 
(3) Accurate diagnosis often involves a multidisciplinary team approach. Objective 
assessment tools such as full PSG and screening tools for sleep disorders are essential for 
accurate diagnosis and treatment protocols. Clinical health psychologists in South Africa 
should be alert to the risk factors and behaviours indicative of OSA. OSA behaviour is 
complex at a number of different levels. At a physiological level the airway is 
undermined with resultant oxygen desaturation and sleep fragmentation. Autonomic and 
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metabolic function interact with genetic and environmental factors to determine the 
severity of risk for other diseases. 
Psychological problems are a manifestation of these factors. For example the sort of 
depression found in OSA patients has origin in the fragmented sleep and physiological 
deficit experienced. Thereafter, it is compounded by personal and social difficulty in 
relation to the personal impact of the condition. The treatment therefore requires support, 
advocacy, encouragement, education and intensive psychotherapy for patients and their 
significant few. Family and group work may also be pertinent. Consultancy to 
companies, schools and other institutions may be appropriate. Research into this 
condition and other sleep disorders is still in the cradle in this country - many research 
opportunities are therefore available. We expect that the BQ will pilot these opportunities. 
Furthermore, referrals for psychotherapy where symptoms such as depression, cognitive 
impairment, obesity, daytime sleepiness, cardio-vascular disease and hypertension are 
identified should be warning bells for clinicians. Furthermore, a good history, collateral 
information from a bed-partner and an educated approach to dealing with sleep disorders 
is essential. It is of utmost importance to make the right diagnosis before treatment 
commences. Treating the symptoms without investigating the root cause undermines 
effective and efficient clinical practice. Furthermore it belies ethical practice, particularly 
the "first do no harm" code. 
(4) At a primary health care level in South Africa, recognition, diagnosis and treatment of 
OSA is currently scant. The provincial sector is neglected and elitist options remain the 
norm. The majority of patients in the provincial sector is undiagnosed and is frequently 
treated for superficially presenting problems and psychosocial complications, which 
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overload resources. Policy regarding OSA has not been legislated and the possible costs 
the state an enormous amount of money every year to treat symptoms and side effects of 
the condition. Good examples are hypertension and obesity. Obesity is reaching 
epidemic proportions in this country; many of these patients could be OSA sufferers. The 
personal, psychosocial and clinical impact of this syndrome is profound. Clinical health 
psychologists have the opportunity to diagnose and treat this condition holistically and 
should be educated about OSA. 
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APPENDICES 
APPENDIX A 
THE BERLIN QUESTIONNAIRE - Netzer et al., (1999). 
Completed by physician: 
1. A. Height (cm): 
B. Weight (kg): 
C. BMI (kg/m2): 
BMI > 30? 
• Yes 
• No 
Patient: Please tick the correct box: 
2. Do you snore? 
• Yes 
• No 
I I Don't know 
If you snore: 
3. Your snoring is 
I I slightly louder than breathing 
I I as loud as talking 
I I louder than talking 
I I very loud. Can be heard in adjacent rooms 
4. How often do you snore? 
I I nearly every day 
n 3-4 times a week 
n 1-2 times a week 
D 1-2 times a month 
I I never or nearly never 
5. Has your snoring ever bothered other people? 
D Yes 
• No 
6. Has anyone noticed that you stop breathing during your sleep? 
|~] nearly every day 
G 3-4 times a week 
I I 1-2 times a week 
Q 1-2 times a month 
I I never or nearly never 
7. How often do you feel tired or fatigued after your sleep? 
I I nearly every day 
n 3-4 times a week 
D 1-2 times a week 
D 1-2 times a month 
I I never or nearly never 
8. During your waketime, do you feel tired, fatigued or not able to cope? 
I I nearly every day 
D 3-4 times a week 
D 1-2 times a week 
D 1-2 times a month 
I I never or nearly never 
9. Have you ever nodded off or fallen asleep while driving a vehicle? 
• Yes If 
yes, how often does it occur? 
D No O nearly every day 
D 3-4 times a week 
D 1-2 times a week 
n 1-2 times a month 
I I never or nearly never 
10. Do you have high blood pressure? 
• Yes 
• No 
• Don't Know 
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APPENDIX B 
isiZulu Translation - Berlin Questionnaire (Netzer et al. 1999) 
Translated and back-translated by: 
feff Thomai 
(trading as ASIZWANEINTERCUL TURAL CONSUL TANCY 
11a Hartwell Crescent 
Westville 3630 
Phone/Fax: 031-2625771 Cell: 083-2556055 
E-mai l : asip»>ane(a).sao/.com 
VAT No: 4620210544 
A. Ubude(cm) 
B. Isisindo (kg) 







I I Angazi 
3. Umauhona: 
Ukuhona kwakho ku : 
I I Ngaphezu kancane nje kokuphefumula 
I I Kulingana nokuba ukhuluma 
I I Ngaphezu kokukhuluma 
I I Kuzwakala kakhulu. Kungezwakala kwelinye ikamelo 
4. Ujwayele ukuhona kangaki? 
I I Cishe zonke izinsuku 
I I Kathathu noma kane ngeviki 
I I Kanye noma kabili ngeviki 
I I Kanye noma kabili ngenyanga 
I I Angihoni noma cishe angihoni nhlobo 
5. Ukuhona kwakho kuyabakhathaza abanye abantu? 
• Yebo 
• Cha 
6. Ukhona oke abone ukuthi uke uhiqize uma ulele? 
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I I Cishe zonke izinsuku 
I I Kathathu noma kan ngeviki 
• Kanye noma kabili ngeviki 
• Kanye noma kabili ngenyanga 
I I Akwenzeki noma cishe akwenzeki nhlobo 
7. Kungakaki lapho uzizwa ukhathele noma ucobekile emva kokulala? 
I I Cishe zonke zonke izinsuku 
I I Kathathu noma kane ngeviki 
• Kanye noma kabili ngeviki 
| I Kanye noma kabili ngenyanga 
I I Akwenzeki noma cishe akwenzeki nhlobo 
8. Uma uvukile, uzizwa ukhathele, ucobekile noma ungakwazi kwenza lutho 
nje? 
I I Cishe zonke izinsuku 
| | Kathathu noma kane ngeviki 
I I Kanye noma kabili ngeviki' 
• Kanye noma kabili ngenyanga 
I I Akwenzeki, noma cishe akwenzeki nhlobo 
9. Wake wangquphazela, noma wazumeka ushayela imoto? 
• Yebo 
D C h a 
Uma kwenzeka, kwenzeka kangakanani 
I I Cishe zonke izinsuku 
| | Kathathu noma kane ngeviki 
I I Kanye noma kabili ngeviki 
I I Kanye noma kabili ngenyanga 
I I Akwenzeki noma cishe akwenzeki nhlobo 
10. Unaso isifo sokwenyuka komfutho wegazi 
• Yebo 
• Cha 
I I Angazi 
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APPENDIX C 
EPWORTH SLEEPINESS SCALE (Johns, 1991). 
How likely are you to feel drowsy in the following situations, in contrast to feeling just tired? This refers 
to your usual way of life in the last month. Even if you have not yet done some of these things recently 
try to work out how would they have affected you. Use the following scale to choose the best number 
for each situation. 
0 = would never doze 
1 = slight chance of dozing 
2 = moderate chance of dozing 
3 = high chance of dozing 
SITUATION 
Sitting and reading. 
Watching T.V. 
Sitting inactive in a public place (e.g. a theatre for a meeting). 
Lying down to rest in the afternoon when circumstances permit. 
Sitting and talking to someone. 
Sitting quietly after a lunch without alcohol. 
As a passenger in a vehicle after one hour. 
In a car, while stopped for a few minutes in traffic. 
CHANCE OF DOZING 
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APPENDIX D.l 
CONSENT TO PARTICPATE IN RESEARCH 
(Berea Skep Laboratory 
It — - A A HOOf?rf ^ 3 C « f 7 d i n ) FRCS 21 <**.£ Fax: 031 -2018420 Berea 
Mobile~082 444 9649 4 0 0 1 
Email: anooper0saol.com 
Friday, January 26, 2007 
To whom it may concern 
This is to certify that I have given Mrs Michelle Baker full access to the records from my 
practice to enable her to do her research. 
Furthermore 1 personally supervised the completion of the Berlin Questionaire for each 
patient. I explained the nature and confidentiality of this information and each patient gave 
verbal consent to me personally for Mrs Baker to use the information for the purposes of 
her research. 
C 
A A Hooper 
MB ChB (Edin) FRCS 
APPENDIX D.2 
CONSENT TO PARTICPATE IN RESEARCH 
CONSENT DOCUMENT 
This document was used by the sleep physician as the framework for verbal consent 
on intake of each subject. 
You have been asked to participate in a research study in order to find out if a basic 
questionnaire on Obstructive Sleep Apnoea (OSA) can be used to diagnose OSA. The 
questionnaire you fill out and the sleep study test the doctor sends you home with, will be 
compared by a researcher, Ms. Michelle Baker (Intern Clinical Psychologist, University 
of KwaZulu-Natal, Pietermaritzburg, South Africa). The study is a preliminary study to 
find out if the Berlin Questionnaire can be used in a South African population to diagnose 
OSA, in order to cut down the costs of diagnosing the condition, and make testing 
accessible to all South Africans. 
You have been informed about the study by the sleep physician, Dr. D. Hooper. You may 
contact the researcher any time if you have questions or concerns about your rights as a 
research subject. Dr. Hooper will give you the phone number. 
Your participation in this research is voluntary, you will not be penalised or lose any 
benefits during the course of your sleep study if you refuse to participate or decide to stop 
at any stage. The researcher will need to have access to your file for data loading. If you 
have any objection to this please do not hesitate to inform Dr. Hooper. 
If you agree to participate, you must repeat your understanding of your rights, what is 
expected of you, and give permission to Dr. Hooper for access to the data in your 
laboratory file. This is all done verbally, to protect your confidentiality. Your partner or 
Dr. Hooper's staff will be asked to witness your agreement to participate in the research. 
Thank you 
Dr. D. Hooper and Ms.M.L.Baker appreciate your participation and trust you will feel 
free to voice any concerns you may have during the course of completing the 
questionnaire and sleep study. 
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APPENDIX E 
THE BERLIN OUESIONNAIRE RESUTS - ADDITIONAL INFORMATION 
RESULTS FOR CATEGORY 1 - DESCRIPTIVE BO DATA - SNORING 
Table E-l. Question 2 - Do you snore - BQ data. 























Table E-2. Question 3 -Your snoring. Is... BQ data 
Valid 
Missing 
Slightly louder than 
breathing - Low risk 
As loud as talking -
Low risk 
Louder than talking -
High risk 























Table E-3. Question 4 - How often do you snore -BQ data. 
Valid 
Missing 
1 -2 times a week -
Low Risk 
3-4 times a week -
High Risk 











































Never - Low risk 
1-2 Times a 
month - Low risk 
1-2 Times a week 
- Low Risk 
3-4 Times a week 
- High risk 
Nearly every day 






















RESULTS FOR CATEGORY 2 BO DATA - SLEEPINESS 




Never - Low risk 
1-2 Times a 
month - Low risk 
1-2 Times a week 
- Low Risk 
3-4 Times a week 
- High risk 
Nearly every day 

























Never - Low risk 
1-2 Times a 
month - Low risk 
1-2 Times a week 
- Low Risk 
3-4 Times a 
week- High risk 
Nearly every day 

























Never - Low risk 
1-2 Times a 
month - Low risk 
1-2 Times a week 
- Low Risk 
3-4 Times a week 
- High risk 
Nearly every day 






































RESULTS FOR CATEGORY 3 BO DATA - BLOOD PRESSURE AND BMI 
























No - Low risk 
















HypnoPTT™ RESUTS - ADDITIONAL INFORMATION 
Table F-l. Assessment of OSA severity according to the final results generated by 


























Table F-2. AHI ratings recorded by the HypnoPTT™. 
Valid 
Missing 
< 5 - Normal range 
5 - 20 - Mild range 
>20-30 -Moderate 
range 




















Table F-3. Total number of snores recorded by the HypnoPTT™ . 
Valid 
Missing 
< 20 total snores 
20-100 total snores 
100-300 total snores 

























<14 arousal events per 
hour - normal range 
>14 arousal events per 

















RELIABILITY AND VALIDITY STATISTICS 
Reliability statistics - Internal consistency ofBQ data 
Table G-l. Tables showing reliability statistics 
Reliability Statistics Snoring items 









N of Items 
10 
Sleepiness including driving Sleepiness excluding driving 









N of Items 
3 





N of Items 
2 
A The AHI as dependent variable 
Table G-2. AHI as dependent variable, BQ questions 1-10 as independent variables. 
Table showing results for regression analysis coefficients. 
Model 
1 (Constant) 
Your snoring is...volume of 
snoring BQ data 
How often do you snore -
BQ data 
Snoring bothers others -BQ 
data 
Breath holding during sleep 
How often are you tired or 
fatigued after your sleep- BQ 
data 
Excessive daytime 
sleepiness- BQ data 
Sleepiness whilst driving 
High blood pressure-BQ 
data 




























































R Lowest o2 saturation value as dependent variable 
Table G-3. Multiple regression coefficient results using the lowest oxygen 
saturation value as dependent variable against BQ questions 3-10 
Model 
1 (Constant) 
Your snoring is...volume of 
snoring BQ data 
How often do you snore -
BQ data 
Snoring bothers others -BQ 
data 
Breath holding during sleep 
How often are you tired or 
fatigued after your sleep-
BQ data 
Excessive daytime 
sleepiness- BQ data 
Sleepiness whilst driving 
High blood pressure-BQ 
data 



























































C. Snoring as dependent variable 
Table G-4. Multiple regression analysis showing the results of using total snoring 
as dependent variable against BQ questions 3-10 
Model 
1 (Constant) 
BMI - Berlin 
Your snoring is...volume of 
snoring BQ data 
How often do you snore -
BQ data 
Snoring bothers others -BQ 
data 
Breath holding during sleep 
How often are you tired or 
fatigued after your sleep-
BQ data 
Excessive daytime 
sleepiness- BQ data 
Sleepiness whilst driving 




























































D. The ANA 's as dependent variable 
Table G-5. Regression analysis using ANA's as the dependent variable and BQ 
questions 1- 10 as independent variables 
Model 
1 (Constant) 
Your snoring is...volume of 
snoring BQ data 
How often do you snore -
BQ data 
Snoring bothers others -BQ 
data 
Breath holding during sleep 
How often are you tired or 
fatigued after your sleep- BQ 
data 
Excessive daytime 
sleepiness- BQ data 
Sleepiness whilst driving 
High blood pressure-BQ 
data 




























































RISK CATEGORY ANALYSIS - ADDITIONAL INFORMATION 
SPSS category computation 
Category 1 - Snoring parameters 
IF ((bq2snore >2and bq3volum >2) OR (bq2snore >2and bq4often >2) OR (bq2snore >2 and bq5bothe >2) 
OR (bq2snore >2 and bq6brehold >2) OR (bq3volum >2and bq4often >2) OR (bq3volum >2and bq5bothe 
>2) OR (bq3volum >2 and bq6brehold >2) OR (bq4often >2 and bq5bothe >2) OR (bq4often >2 and 
bq6brehold >2) OR (bq5bothe >2 andbq6brehold >2)) CatlSnore = 1. 
EXECUTE. 
Category 2 - Sleepiness parameters 
IF ((bq7tired >2 and bq8eds >2) OR (bq7tired >2 and bq9drivi >2) OR (bq8eds >2 and bq9drivi>2)) 
Cat2EDS= 1. 
Category 3 - History of high blood pressure & BMI>30kg/m 
IF (bqlObp =1 and bqlcbmi =1) Cat3BPBMI = 1. 
EXECUTE. 
Case BQ — Qualifying for at least 2 of the 3 categories 
IF ((CatlSnore =1 AND Cat2EDS = 1) OR (CatlSnore = 1 AND Cat3BPBMI = 1) OR (Cat2EDS =1 AND 
Cat3BPBMI = 1)) CASEBQ = 1. 
EXECUTE. 
Risk factor category analysis 
Table H-l. Risk category 1 - Snoring parameters 





















Table H-2. Risk category 2 - Sleepiness parameters 




















Table H-3. Risk category 3 - High blood pressure and/ 
or BMI >30 Kgs/m2. 
Category 3 -




















Table H-4. High risk cases - qualifying for at least 2 of the 3 categories 
High Risk Qualifiers 
Valid 
Missing 
Low risk cases 
















Table H-5. High risk cases predicting an AHI >5 
High risk- AHI>5 
Valid 
Missing 
Does not qualify 

















Table H-6. Multinomial regression analysis using AHI ratings as dependent 





































































CONSTRUCT VALIDITY- ADDITIONAL DATA 
CORRELATION COEFFICIENTS. 



























Do you snore 


















































Correlation is significant at the 0.01 level (2-tailed). 
Table 1-2. Correlations with the physicians result and the AHI for sleepiness questions - Category 2 
AHI Total 


























How often are 
you tired or 
fatigued after 





























Correlation is significant at the 0.01 level (2-tailed). 
Table 1-3. Correlations for the physician's result and the 
AHI with BMI and High Blood Pressure - Category 3 
Correlations 
AHI Total Pearson Correlation 
Sig. (2-tailed) 
N 
Result -physician Pearson Correlation 
result - PTT data 
Sig. (2-tailed) 
N 




























































** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed). 
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APPENDIX J 
VISUAL COMPARISON OF THE OBJECTIVE RECORDING OF 
THE AHI AND THE SUBJECTIVE ACCOUNT OF BREATH-
HOLDING EPISODES 
< 5 - Normal 
range 




>30 - Severe 
range 
Never- 1-2 Times 1-2 Times 3-4Times Nearly 
Low risk a month - a week - a week - every day 
Low risk Low Risk High risk - High risk 
Breath holding during sleep 
Figure J-l. Visual comparison of the AHI (objective) and breath-holding 
events (subjective rating). 
APPENDIX K 
HIGH-RISK CATEGORY ANALYSIS ALGORITHM 















(Qualifies as high risk for any 2 Categories) 
CASEBQ —^ 
60%/ 




3. Predictive Validity -Multinomial regression analysis 
Model 1 - Case BQ & AHI Ratings 
(Unstable) 
0-5 5-20 20-30 30+ 
57% 0 0 81% 
Model 2 - BQ Categories & AHI Ratings 
(Stable) 
0-5 5-20 20-30 30+ 
54% 64% 0 25% 
DIAGNOSTIC VALUE 
Consensus criteria used for rating 
Snoring, sleepiness and BP/BMI 
symptoms >3-4Xper week. 
Combines categories = one group 
High-Risk BQ Group. 
The BQ identify >half the sample 
=AHI>5 (OSA risk) 
Cases BQ predictive value 
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